Michigan Technological University

Digital Commons @ Michigan Tech
Dissertations, Master's Theses and Master's Reports
2020

STUDY OF SILICA NANOPARTICLE COMPOSITE ON SILICAHYDROGEN PEROXIDE COMPLEXATIONS AND THEIR EFFECTS IN
CATECHOL BASED ADHESIVES
Rattapol Pinnaratip
Michigan Technological University, rpinnara@mtu.edu

Copyright 2020 Rattapol Pinnaratip
Recommended Citation
Pinnaratip, Rattapol, "STUDY OF SILICA NANOPARTICLE COMPOSITE ON SILICA-HYDROGEN PEROXIDE
COMPLEXATIONS AND THEIR EFFECTS IN CATECHOL BASED ADHESIVES", Open Access Dissertation,
Michigan Technological University, 2020.
https://doi.org/10.37099/mtu.dc.etdr/1044

Follow this and additional works at: https://digitalcommons.mtu.edu/etdr
Part of the Biomaterials Commons

STUDY OF SILICA NANOPARTICLE COMPOSITE ON SILICA-HYDROGEN
PEROXIDE COMPLEXATIONS AND THEIR EFFECTS IN CATECHOL BASED
ADHESIVES
By
Rattapol Pinnaratip

A DISSERTATION
Submitted in partial fulfillment of the requirements for the degree of
DOCTOR OF PHILOSOPHY
In Biomedical Engineering

MICHIGAN TECHNOLOGICAL UNIVERSITY
2020

© 2020 Rattapol Pinnaratip

This dissertation has been approved in partial fulfillment of the requirements for the
Degree of DOCTOR OF PHILOSOPHY in Biomedical Engineering.

Department of Biomedical Engineering

Dissertation Co-advisor:

Bruce P. Lee

Dissertation Co-advisor:

Rupak M. Rajachar

Committee Member:

Feng Zhao

Committee Member:

Smitha Rao

Committee Member:

Lanrong Bi

Department Chair:

Sean J. Kirkpatrick

Dedicated to my loving mother

Sureerat Pinnaratip

Table of Contents
List of figures ..................................................................................................................... ix
List of tables..................................................................................................................... xvi
Preface............................................................................................................................. xvii
Acknowledgments............................................................................................................ xix
Abstract ............................................................................................................................ xxi
1

Multifunctional Catechol Adhesive Composite Design .............................................1
1.1

Introduction ......................................................................................................1

1.2

Key criteria for biomedical adhesive design ....................................................4
1.2.1

Interfacial interactions ........................................................................4

1.2.2

Curing of adhesive and cohesive properties .......................................7

1.2.3

Biocompatibility and biodegradability of biomedical adhesives ........8

1.3

ROS production from Catechol adhesive .........................................................8

1.4

H2O2 and its biological functions ...................................................................10

1.5

H2O2 degradation and control method............................................................12

1.6

Silica particle as reinforcement and bioactive additives ................................12

1.7

Statement of purpose and experiment set-up .................................................14

iv

2

Synthesis, Modification, and Characterization of Silica Particle and Catechol-Based

Polyethylene Glycol Adhesive ...........................................................................................17
2.1

3

Synthesis, Modification, and Characterization of Silica Particle ...................17
2.1.1

Understanding Silica Particle and Their Biological Effect ...............17

2.1.2

Stӧber Synthesis Method ..................................................................20

2.1.3

Exploratory Experiment on Modified Stӧber Synthesis Method ......21
2.1.3.1

Material ...........................................................................21

2.1.3.1

Method ............................................................................22

2.1.4

Surface modification .........................................................................26

2.1.5

Characterization methods..................................................................29

Controlling the Release of Hydrogen Peroxide from Catechol-Based Adhesive

Using Silica Nanoparticle ..................................................................................................31
3.1

Abstract ..........................................................................................................31

3.2

Introduction ....................................................................................................32

3.3

Materials and methods....................................................................................35
3.3.1

Materials ...........................................................................................35

3.3.2

Synthesis of Silica Particles ..............................................................36

3.3.3

Silica Particle Modification ..............................................................37

3.3.4

Silica Particle Surface and Composition Characterization ...............37

3.3.5

Adhesive Formation ..........................................................................38

3.3.6

Physical and Chemical Characterization of the Adhesive ................39
v

3.4

4

3.3.7

In vitro Cell Viability ........................................................................41

3.3.8

In vitro Cell Proliferation ..................................................................42

3.3.9

Statistical analysis .............................................................................44

Results and discussion ....................................................................................44
3.4.1

Characterization of Si Particles .........................................................44

3.4.2

Effect of Silica Particle on H2O2 Decomposition ............................47

3.4.3

Preparation and Characterization of Composite Adhesives..............48

3.4.4

Effect of Incorporating Si Particle in PEG-DA on Cellular Response58

3.5

Conclusions ....................................................................................................63

3.6

Acknowledgements ........................................................................................64

Systemic Study of Silica Particle-Catechol Composite Adhesive on Dermal Wound

Repair in Mice3 ..................................................................................................................65
4.1

Abstract ..........................................................................................................65

4.2

Introduction ....................................................................................................65

4.3

Materials and methods....................................................................................68
4.3.1

Materials ...........................................................................................68

4.3.2

Synthesis, Preparation, and Characterization of PEG-DA Adhesives

and their composites .......................................................................................68
4.3.3

Systemic Study of H2O2 Release in PEG Adhesive Composites......70

vi

4.4

4.3.4

Systemic Study of PEG Composites in Dermal Wound Model in

Mice

72

4.3.5

Full Thickness Dermal Wound Repair model ..................................74

4.3.6

Immunological and Histological Analysis of Dermal Wound Model76

4.3.7

Statistical Analysis ............................................................................78

Results and discussion ....................................................................................79
4.4.1

A systemic study of H2O2 release in PEG adhesive composites .....79

4.4.2

Dermal Wound Model in mice .........................................................84
4.4.2.1

5

Wound closure ................................................................84

4.4.3

Immunological Analysis of Dermal Wound Model..........................86

4.4.4

Histological Analysis of Dermal Wound Model ..............................90

4.5

Conclusions ..................................................................................................103

4.6

Acknowledgments ........................................................................................104

Summary and Future Outlook .................................................................................105
5.1

Summary ......................................................................................................105

5.2

Future Outlook .............................................................................................106

6

References ...............................................................................................................108

A

Copyright documentation........................................................................................118
A.1

Permission for content in Chapter 1 .............................................................118

vii

A.2

Permission for content in Scheme 1 .............................................................119

A.3

Permission for content in Figure 4A ............................................................121

A.4

Permission for content in Figure 4B.............................................................123

A.5

Permission for content in Scheme 2 .............................................................125

A.6

Permission for content in Chapter 3 .............................................................126

Appendix A. .....................................................................................................................127

viii

List of figures
Figure 1. Multifunctional biomedical adhesive design considerations. The
fundamental attributes of any successful biomedical adhesive include an
application-specific balance of appropriate cohesive and adhesive interactions
coupled with the biocompatibility of the bulk adhesive material as well as any
products generated during the curing process or degradation of the adhesive with
time. Passive and active design elements can be used to ultimately tailor or refine
these core attributes in multi-functional bioadhesives to more specifically target
an overall desired outcome. .....................................................................................3
Figure 2. Interfacial crosslinking chemistries between adhesive functionalized using
NHS-activated ester (A), isocyanate (B), aldehyde (C), and catechol (D) with
nucleophilic functional groups (e.g., -NH2 of lysine) found on soft tissues.
Catechol can also form coordination bonds with metal oxide surfaces, which may
be present on the surface of an implant or medical device (E). ...............................6
Figure 3. NaIO4-mediated catechol oxidation to quinone and crosslinking. ROS, such as
superoxide (O2˙‒) and hydrogen peroxide (H2O2), are generated during the
process. R = PEG polymer .......................................................................................9

ix

Figure 4. Basic-catalyzed silica hydrolysis and condensation (A) and acid-catalyzed
silica hydrolysis and condensation. Reprint from ref. 71 and 69, with permission
from Elsevier copyright 2020 and The Royal Society of Chemistry, respectively19
Figure 5. Equipment setup for silica particle surface modification. Yellow box indicates
the flask convertor and reflux column connection .................................................23
Figure 6. Effects of pH value on the silica condensation rate, charge properties, and
charge density on the surface of the silica species. Reproduced from Ref. 72 with
permission from The Royal Society of Chemistry. ...............................................29
Figure 7. XRD spectra of HSi, AHSi, LSi, and NSi. Pink markings indicate correlated
crystalline SiO2 crystal spectra, cristobalite...........................................................30
Figure 8. STEM images of non-porous silica nanoparticle (NSi) (A), porous silica
nanoparticle (LSi) (B), highly porous silica nanoparticle (HSi) (C), and acid-heat
treated highly porous silica nanoparticle (AHSi) (D). Scale bars are 50 nm. ........46
Figure 9. Particle size distribution of silica particles. * p<0.05 when compared to each
other. ......................................................................................................................46
Figure 10. Surface area of Si particles determined using BET N2 sorption. *p<0.05 when
compared with each other. .....................................................................................47
Figure 11. Relative H2O2 concentration after incubation with Si particles or 1000 units of
catalase at pH 7.4 and 37oC. The starting H2O2 concentration was 100 µM. ........48
x

Figure 12. Gelation time of PEG-DA and its composite containing different silica
particles. *p<0.05 when compared to PEG-DA. **p<0.05 when compared to
PEG-DA and PEG-NSi. .........................................................................................49
Figure 13. FTIR spectra of the Si particles (A) and PEG-DA containing the Si particles
(B). Dash lines indicate (from left to right for A and B) Si-O-Si (1065 and 1030
cm-1), Si-OH (950 and 960 cm-1), and Si-O-Si (800 and 790 cm-1) peaks. ...........51
Figure 14. Storage (A) and loss (B) modulus of PEG-DA and its composite containing
different silica particles. .........................................................................................52
Figure 15. Lap shear adhesion strength of PEG-DA and its composite containing
different silica particles using bovine pericardium as the test substrate. *p<0.05
when compared to PEG-DA. **p < 0.05 when compared to PEG-DA and PEGNSi .........................................................................................................................54
Figure 16. Normalized residual weight of PEG-DA and its composite containing
different silica particles. The samples were incubated in PBS (pH 7.4) at 37 °C.
*p<0.05 when compared to all other groups ..........................................................56
Figure 17. Soluble Si content of PEG-DA and its composite containing different Si
particles after 24 hour incubation in complete medium at pH 7.4 and 37oC. *
p<0.05 when compared to all other groups ............................................................57

xi

Figure 18. H2O2 concentration of PEG-DA and its composite containing different Si
particles. * p<0.05 when compared to all other groups. ** p<0.05 when compared
to PEG-DA and PEG-NSi ......................................................................................58
Figure 19. MTT signal relative to culture medium control for primary rat dermal
fibroblast (A), human epidermal keratinocytes (B), and human tenocyte (C) after
incubated with PEG-DA and its composite containing different Si particles for 24
hours in complete medium at pH 7.4 and 37oC. *p<0.05 when compared to PEGDA. ** p<0.05 when compared to all other groups, respectively..........................61
Figure 20. Percentage of cells that were Ki-67 positive and the total cell count for
primary rat dermal fibroblast (A), human epidermal keratinocyte (B), and human
tenocyte (C) exposed to adhesive for 24 hours in complete medium at pH 7.4 and
37oC. * p<0.05 when compared to all other groups ...............................................62
Figure 21. Illustration (A) and photograph (B-I) of the step-by-step process of fullthickness wound repair model in mice...................................................................75
Figure 22. Chemical Structure of PEG-D4, PEG-D6, and PEG-D8. Single carbon (A),
dipentaerythritol (B), and hexaglycerol (C) were used as the center group. .........80
Figure 23. Prediction vs. Experimental result of gelation time (A), maximum H2O2
concentration (B), and adhesion strength (C). *p<0.05 when compared to their
pair .........................................................................................................................83

xii

Figure 24. Representative image of the harvested tissue at day 0 (top), 7 (middle), and 14
(bottom) of control (A,F,K), PEG-D6 (B,G,L), PEG-D6-AHSi(C,H,M), PEG-D4AHSi (D,I,N), and PEG-D8-AHSi (E,J,O). Red and yellow dash line indicates the
wound area. Scale bars are 1 cm. ..........................................................................84
Figure 25. The wound area of the control wound and wound treated with different
formulations of the adhesive. *p<0.05 when compared to their pair.....................85
Figure 26. Histological analysis of skin structure and thickness. Scheme of skin structure
(A), histological skin sections stained with Masson trichrome and collected from
young (8-12 week-old) and old (16-20 week-old) mice fed with normal diet for a
period of 8 weeks (B), quantification of the skin layers thickness: the epidermis
(C) Epi - epidermis, dWAT - dermal white adipose tissue, F-rd fibroblast rich
dermis; scale bar 200 μm. Adapted from reference

144

under the terms of the

Creative Commons Attribution License (CC BY 3.0) ...........................................91
Figure 27. Representative trichrome histological image of the harvested tissue on day 7
after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi
(D), and PEG-D8-AHSi (E). Black (A-B) and Yellow (C-E) dash line indicate the
area used to calculate collagen content. White dash line indicates the wound
proximities. es = eschar, gr = granulation tissue, and ep = epidermis. Scale bars
are 1 mm. ...............................................................................................................94

xiii

Figure 28. Representative trichrome histological image of the harvested tissue on day 14
after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi
(D), and PEG-D8-AHSi (E). Black (A and C) and Yellow (B, D, and E) dash line
indicate the area used to calculate collagen content. White dash line indicates the
wound proximities. es = eschar, gr = granulation tissue, and ep = epidermis. Scale
bars are 1 mm. ........................................................................................................95
Figure 29. The epidermis thickness (A) and collagen layer thickness (B) of the wound
treated with different formulation of the adhesive. *p<0.05 when compared to
their pair .................................................................................................................96
Figure 30. Representative keratin-6 histological staining images of the harvested tissue at
day 7 of control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D), and
PEG-D8-AHSi (E). Red dash line indicates the area used to calculate keratinocyte
content. White dash line indicates the wound proximities. Scale bars are 1 cm. ..98
Figure 31. Representative keratin-6 histological staining images of the harvested tissue at
day 14 of control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D), and
PEG-D8-AHSi (E). Red and yellow dash line indicates the area used to calculate
keratinocyte content. White dash line indicates the wound proximities. Scale bars
are 1 cm. .................................................................................................................99
Figure 32. The wound size of the wound treated with different formulation of the
adhesive (F). *p<0.05 when compared to control ...............................................100

xiv

List of Scheme
Scheme 1. Schematic representation of the chemical interactions involved in the curing
and adhesion processes of the composite adhesive. PEG-DA contains catechol
end-groups that can interact with silica nano- and microparticles (NP and MP,
respectively) through strong reversible interactions (A). Oxidation of catechol in
the presence of NaIO4 forms highly reactive quinone, which results in catechol
polymerization and curing of the adhesive (B), as well as the formation of an
interfacial covalent bond with nucleophilic function groups (i.e., –NH2 of lysine)
and adhesion to the surface of soft tissue (C). Reproduced from reference 64 with
permission from IOP Publishing copyright 2020. .................................................14
Scheme 2. representation of simplified Stöber synthesis. Reproduce from Ref.

70

with

permission from Elsevier copyright 2020 ..............................................................21
Scheme 3. Schematic Representation of Mixing PEG-DA with Porous Si Particles to
Form a Composite Adhesive (A); Catechol Generates H2O2 During Oxidative
Crosslinking (B); Surface Si–OH Forms Complexation with H2O2 and Water,
Resulting in H2O2 Degradation (C)........................................................................34
Scheme 4. H2O2, material property, and AHSi on dermal wound healing ......................102

xv

List of tables
Table 1. H2O2 concentration and their correlated biological effect ..................................11
Table 2. Exploratory silica particle synthesis condition ...................................................23
Table 3. Exploratory surface modification condition........................................................27
Table 4. Formulation required to fulfill the robust design matrix requirement ................71
Table 5. Formulation to be tested with the full thickness dermal wound in mice ...........72
Table 6. Full list of treatments for all mice in the full thickness dermal wound repair
experiment..............................................................................................................73
Table 7. Experimental result of the formulations required to fulfill the robust design
matrix requirement .................................................................................................81
Table 8. Predicted formulation that fit the criteria for dermal wound repair ...................82

xvi

Preface
The material used in Chapter 1 of this dissertation was previously published in Advanced
healthcare materials, 8(11), p.1801568. This article was republished in parts which are
relevant with permission from ACS Publications. The material used in Chapter 2 of this
dissertation was previously published in Biomedical Materials, 13(2), p.025003. This
article was reproduced in parts which are relevant with permission from IOP Publishing,
LTD. The material used in Chapter 3 of this dissertation was previously published in ACS
Biomater. Sci. Eng., 2020, (page not yet assigned). This article was reproduced in its
entirety with permission from ACS Publications.
In Chapter 3, I have synthesized all materials, collected, and analyzed the data, as well as
written the manuscripts for first-authored publications that are a part of this dissertation.
Dr. Bruce P. Lee has guided me through my research and also supported my work with
his grants. Dr. Rupak M. Rajachar has guided me through the biological aspect of the
research. Applied Chemical and Morphological Analysis Laboratory (ACMAL) at
Michigan Technological University’s facility and staff have given me support for all the
FE-SEM, SEM, TEM, and XRD. Meijia Li performed the Brunauer, Emmett, and Teller
(BET) surface area analysis with the supporting grant from Dr. Yun Hang Hu. Pegah
Kord Forooshani has helped as a supporter for the cell experiments.
The data presented in Chapter 4 of this dissertation is a manuscript in preparation to be
submitted to ACS Biomater. Sci. Eng. (ACS Publications). The research was conducted in
xvii

Dr. Bruce P. Lee’s lab, Animal Care Facility (ACF) at Michigan Technological
University, and Applied Chemical and Morphological Analysis Laboratory (ACMAL) at
Michigan Technological University. Pegah Kord Forooshani has helped as a supporter
during the animal experiments. Ariana G. Tyo has helped with animal tissue processing
and imaging.
The abstract, latter part of Chapter 1 (page 8-page 16), Chapter 2, summary, and future
outlook sections were specifically written exclusively for this dissertation.

xviii

Acknowledgments
After I got my scholarship from the Thai Government Scholarship program per request of
Chiang Mai University, Chiang Mai, Thailand. I got accepted to Michigan Technological
University as a Master student, following my undergraduate’s project advisor, Dr.
Bovornlak Oonkanond, who is a Ph.D. graduate from Tech in the class of 2003. I started
my Master's student’s journey in Dr. Rajachar’s Lab back in the spring of 2013, and then
I later join Dr. Bruce P. Lee’s lab in early Fall 2013. My background was in Biomedical
Engineering with a focus on bioinstrumentation and electronics with minimal knowledge
of cell biology and material science. I still remember the first time that I discuss the silica
particle synthesis project with Dr. Rajachar and found out that my knowledge in that
particular field is still lagging. Just after a six-month trial period, Dr. Rajachar introduced
me to Dr. Lee, I still sometimes wonder what Dr. Lee saw in me that made him accept me
into his lab group as my co-advisor. However, what I am very confident about is that
from that day onward until today, both of my co-advisors have been constant supports to
me in achieving all my academic goals. Dr. Rajachar was strict and kept pushing me
forward in the first few years as he believed in me. This made me reached a new height in
academic thinking and research conduct. Dr. Lee has always guided me in the right
direction, and his advice has proved to be of utmost value in my pursuit to learn and grow
as an independent scientist. Both kept reminding me that I will have to make things
simpler and explain my finding in the easier to understand manner; I still keep Dr.
Rajachar's comment with me (a single “Simple” on a piece of paper). I would always like
xix

to remember Dr. Lee’s strict work ethic and how he trained me to see the big picture and
how to plan ahead effectively (I generally over planned my experiment, as Dr. Lee
always said). Dr. Lee has also generously funded all my research with his grants. I was
also supported by the Portage Health Foundation Fellowship in the Spring of 2020. I
would like to thank my committee members, including Dr. Feng Zhao, Dr. Smitha Rao,
and Dr. Lanrong Bi, who have shared their valuable knowledge to further my research.
I am almost always a lone wolf in my research, but I made good friends and colleagues
along the way. My thanks go to the Pegah Kord Forooshani, Ariana G. Tyo, and
Zhongtian Zhang, who helped me with the last stretch of my research while the pandemic
of 2020 is ongoing at the time of writing. I appreciated the time and discussion that I had
with Hao Meng, Yuan Liu, Ameya Narkar, and Saleh. They help me grow and more
adapt to the way of Ph.D. research.
Next, I would like to thank my younger brother, Supawit, who has been taking care of the
family back home allowing me to focus fully on pursuing this degree. I would like to also
thank my aunt, Nopparat, who sacrifice as much if not more than my mother to help take
care of us brothers since birth. I am what I am today owning to your dedication.
Last but certainly not the least, I am thankful for all the help and assistance that the office
and administration staff including Nancy, Cory, and others. I am lucky to have such a
great support for all my year here at tech. I do hope that in my future endeavor I would
encounter such experience again!

xx

Abstract
Mussel adhesive proteins contain catechol moiety, which allows the protein to
crosslinked, solidify, and adhere to surrounding surfaces even under wet conditions.
Incorporating the catechol moiety into polymeric adhesive resulted in bioadhesive, which
still functions under wet conditions. However, the adhesive must be oxidized in order to
crosslink and adhere to surfaces. The oxidation process of catechol adhesive was proven
to produce singlet oxygen, superoxide, and hydrogen peroxide (H2O2). These reactive
oxygen species, with lack of control, can wreak havoc to the biological system causing
poor healing and undesired biological response.
Here, we studied the silica particle system as a means to control H2O2 concentration.
After an exploratory investigation on silica particle synthesis and modification, acidtreated silica particle (AHSi) was developed with a highly hydrophilic surface. We then
explore the use of reinforcement phase incorporation, creating particle-adhesive
composites and studied the effect which the particle incorporation imparts into the
adhesives. The model adhesive is polyethylene glycol functionalized with glutaric acid
and dopamine, creating a biodegradable adhesive hydrogel. We demonstrated that
incorporation of a model particle, silica particle, into a catechol adhesive resulting in a
mechanically stronger adhesive with an increase in stiffness, adhesion strength, and
structural integrity even after partially degraded. Moreover, the composite adhesive was
gelled faster and degrade slower than native PEG-DA adhesive. The composite also

xxi

demonstrated a reduction in the concentration of H2O2. The particle not only reduces
H2O2 but also found to be releasing soluble silica in a biologically relevant concentration
further improve their bioreactivity. The silica nanoparticle incorporated catechol-based
composite demonstrated a reduction in cytotoxicity on rat dermal fibroblast, human
keratinocyte, and human tenocyte, three types of cells that react differently to elevated
oxidative stress.
Interestingly, all cell types have demonstrated an increase in cell proliferation, raising the
possibility of developing the composite adhesive further. The last part of the study
involved a prediction model that helps narrow down the formulation to be tested in vivo.
Full-thickness dermal wound model in mice was utilized to study the predicted
formulation. The results from the animal model suggested that PEG adhesive alone can
alter the biological response with accelerated wound healing. However, the incorporation
of AHSi proved to successfully bridge the gap between accelerated wound healing and
better wound remodeling. This dissertation describes various strategies used to tune the
H2O2 concentration released from catechol adhesives to tune its biological response
which involved silica particle modification with minimal change in chemical
composition, and the selection of adhesive formulation to enhance the wound healing and
wound remodeling.

xxii

1 Multifunctional Catechol Adhesive Composite Design1
1.1 Introduction
Wound closure, surgical repair, and reconstruction of traumatized or degenerated soft
tissues frequently occur in medicine. These procedures involve rejoining biological tissue
surfaces or securing implantable devices (e.g., surgical meshes, grafts, etc.) to living
tissues 1-3. Conventionally, the use of sutures and staples have been the primary means to
achieve such wound closure or implant fixation

4-6

. However, these methods lead to

additional trauma, leakage, and a lack of tissue integration resulting from significant
compliance mismatch between the tissue and the fixation device

7-10

. Biomedical

adhesives can potentially overcome these limitations and provide additional benefits such
as reducing surgical time, minimizing treatment invasiveness, reducing additional trauma,
and preventing body fluid leakage 1-3, 11, 12.
Despite the potential benefits of tissue adhesives, commercially available bioadhesives
have limited applications due to limited functionality. Specifically, existing adhesives are
primarily designed to have one key function, which is to provide mechanical support for
the repaired tissue. To expand the potential utilization of bioadhesive in medicine,
researchers

have

reported

novel

multifunctional

bioadhesives

with

improved

performance. Multifunctional bioadhesives not only need to meet the requirement of

1

Parts of the material contain in this chapter was previously published in Advanced healthcare
materials, 8(11), p.1801568. https://onlinelibrary.wiley.com/doi/full/10.1002/adhm.201801568

1

adhering to biological tissues but also have added functions aimed at improving the
outcome of the wound healing process. Biomedical adhesives can be engineered to have
an antimicrobial property to minimize microbial growth and prevent acute complications.
Some bioadhesives are also designed to self-heal when damaged, which will prolong the
service life of the adhesive. Stimuli-responsive bioadhesives are designed to respond to
externally applied triggers such as pH, electricity, temperature, light, or changes in the
wound environment to promote cellular migration, tissue-specific gene expression, and
native tissue healing. The ability to respond to externally applied stimuli enables these
adhesive to release therapeutic drugs or change their adhesive property on command in
response to dynamic physiological conditions.
Recent advances in mono-functional bioadhesives have been reviewed elsewhere 1-3, 13, 14,
and will not be the focus of this review. Instead, this review paper focuses on
multifunctional bioadhesives, which we categorize into either passive or active by design
(Figure 1). Passive multifunctional bioadhesives contain inherent compositions and
structural designs that can carry out additional functions (e.g., antimicrobial property,
self-healing ability, etc.) without the need for added external factors or influences.
Conversely, active multifunctional bioadhesives respond to environmental changes (e.g.,
pH, electricity, temperature, light, biomolecule concentration, etc.), which triggers a
chemical or structural change within the adhesive that initiate the added function of the
adhesive. These environmental triggers could be applied externally by the user after the
adhesive has been deployed or internally triggered resulting from the natural
physiological responses to the presence of the adhesive (e.g., normal wound healing
2

response) or physiological conditions of the biological environment (e.g., elevated insulin
concentration in a diabetic patient). In this review, we address fundamental criteria for
designing a bioadhesive, review the existing bioadhesives in the market, and review
passive and active multifunctional bioadhesives reported in the literature.

BIOMEDICAL ADHESIVES
ADHESIVE
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Interfacial Bonding

COHESIVE
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Material Strength

BIOCOMPATIBILIT
Y
Cytotoxicity
Degradation products

ACTIVE DESIGN

PASSIVE DESIGN
Inherent composition-structure
Chemical modification
Multi-element composites
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Adhesion
Drug/cell
conductivit
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y
Promote cell
Fit-to-shape

healing

infiltration
sealant
Figure 1. Multifunctional biomedical adhesive design considerations.

The

fundamental attributes of any successful biomedical adhesive include an applicationspecific balance of appropriate cohesive and adhesive interactions coupled with the
biocompatibility of the bulk adhesive material as well as any products generated during
the curing process or degradation of the adhesive with time. Passive and active design
elements can be used to ultimately tailor or refine these core attributes in multi-functional
bioadhesives to more specifically target an overall desired outcome.

3

1.2 Key criteria for biomedical adhesive design
Regardless of the type, function, or the intended application of a bioadhesive, there are
three key criteria that all bioadhesives should satisfy

1-3, 11-14

. These criteria include the

ability to form strong interfacial bonds, the ability to retain strong bulk cohesive
properties after curing, and the necessity to remain biocompatible throughout the lifetime
of the bioadhesive. This section reviews these key design criteria for bioadhesives.

1.2.1

Interfacial interactions

Biomedical adhesives need to form strong interfacial bonds with tissue substrates

11, 12

.

For fixation of surgical implants, bioadhesive may need to adhere strongly to surfaces
with different surface properties and chemical makeup (i.e., metal, polymer, ceramic).
These interfacial bonds can include chemical crosslinking, physisorption, diffusion,
electrostatic interaction, physical interlocking, and micromechanical interactions. Most
bioadhesives utilize more than one type of interaction to bond to these surfaces. Chemical
crosslinking consists of strong interfacial covalent bonds (Figure 2). Commonly used
interfacial chemistries involve activated ester (e.g., N-hydroxysuccinimide (NHS)
activated acid group), isocyanate, and aldehyde functional groups, which are reactive
toward primary amine found on the surface of soft tissues (e.g., -NH2 of lysine)

13

.

Catechol mimics the reactivity of the adhesive amino acid, 3,4-dihydroxyphenylalanine
(DOPA), found in mussel adhesive proteins

15, 16

. The catechol-modified adhesive is

capable of binding to both tissue and inorganic substrates (i.e., polymer, metal).

4

Additionally, catechol-dimerization has also been shown to enhance wet adhesion
toughness

17

. Physisorption involves weak intermolecular forces such as van der Waals

interaction resulting from positively and negatively charged regions within bonding
molecules

18

. Physisorption is known to perform poorly within a moisture-rich

environment as water interferes with the weak molecular interaction

19

. As such, a

bioadhesive that relies solely on van der Waals interaction may not be effective in a
biological system. Diffusion of polymer networks across interfaces occurs when the
adherent and substrate surfaces are mutually soluble, and their polymer chains have
sufficient mobility

18

. Polymer diffusion is favorable in highly hydrated conditions and

may be limited to bioadhesives designed for moisture-rich environments, such as blood
vessel or digestive tracks. Ionic adhesives with positive or negative charges can bind to
surfaces with the opposite charge through electrostatic interactions

20

. Electrostatic

interaction can be modulated by changing the ionic environment surrounding the
adhesive, which may be useful in designing smart adhesives that respond to changes in
pH.
Depending on the desired application, there may be different performance criteria that the
bioadhesive needs to satisfy. For example, Pascual et al. 21 reported that abdominal wall
repair using a surgical mesh required a fixation strength of 55-60 N, and cyanoacrylatebased adhesive was equally as successful as suture fixation. Sutures have high tensile
strength (8 to 15 N)22 and require minimal footprints for repair. However, the
performance of bioadhesives is highly dependent on the overlapped surface area between
the adhesive and the substrates. To perform microneural anastomosis, Choi et al.
5

23

overlapped the epineuriums of the two nerve ends and then applied cyanoacrylate-based
adhesive. This method was comparable to sutured anastomosis. To function as a lung
sealant, a burst pressure of 30-60 mmHg may be sufficient

3, 24

. However, a significantly

higher burst pressure (200-400 mmHg) may be required for sealing renal veins

25

or

sutured intestinal anastomosis 26. Hence, to design an effective adhesive, it is necessary to
understand the parameters specific to the surgical procedures.

A

B

C

D

E

Figure 2. Interfacial crosslinking chemistries between adhesive functionalized using
NHS-activated ester (A), isocyanate (B), aldehyde (C), and catechol (D) with
nucleophilic functional groups (e.g., -NH2 of lysine) found on soft tissues. Catechol can
also form coordination bonds with metal oxide surfaces, which may be present on the
surface of an implant or medical device (E).

6

1.2.2

Curing of adhesive and cohesive properties

In addition to forming strong interfacial bonds, a bioadhesive must also develop cohesive
strength after it has been applied. The adhesive must remain stable for the duration of its
service life to provide adequate support for a wound to heal. For an injectable
bioadhesive, the adhesive must be able to transform from the liquid state into the solidstate under mild physiological conditions. This physical change should be rapid (typically
3 to 5 minutes) to minimize surgical procedure time 1. The curing process typically
involves the formation of intermolecular crosslinking, which can be achieved via the
mixing of reactive components or activated by external stimuli such as ultraviolet (UV)
light

27

. However, the use of longwave UV (e.g., UVA) is preferred over medium-wave

UV (UVB) to minimize tissue damage 28. After curing, the bioadhesive must possess the
bulk mechanical strength necessary to withstand mechanical forces applied by the
surrounding tissues. A tissue adhesive with adhesive strength and biomechanical
properties matching those of native tissues can potentially be used to repair tissues that
routinely experience repeated loads (e.g., cartilage, tendon, and ligament). Ideally, a
bioadhesive must be designed to match the material properties of the target tissue (e.g.,
elastic modulus of 102-104 Pa for soft connective tissue and >104 Pa for muscle, cartilage,
and bone)29.

A tightly secured tissue repair will allow patients to undergo early,

aggressive rehabilitation programs to promote regeneration of functional tissue, which is
especially critical for relatively avascular tissues that are known to heal poorly otherwise.
Bioadhesives with enhanced bulk mechanical properties also exhibit better adhesion
performance 30. Additionally, it is important to control the swelling behavior of the cured
7

adhesive. Hydrophilic bioadhesives can potentially swell excessively, which is
undesirable as it can lead to severe medical complications such as local nerve
compression

31, 32

. Increased water content can also compromise the mechanical

properties of the adhesive due to decreased crosslinking density

1.2.3

33

.

Biocompatibility and biodegradability of biomedical adhesives

One of the key criteria for a bioadhesive is that it needs to remain biocompatible during
deployment as well as during its service life 34. The typical curing process of an adhesive
involves chemical crosslinking, and it is important that the release of reactive chemicals
into the surrounding tissue is minimized. The introduction of the bioadhesive into the
body is expected to generate an acute inflammatory response. However, it is not desirable
for the bioadhesive to illicit sustained chronic responses 35. In addition, unlike sutures or
staples, adhesives can act as a barrier to the union of tissue surfaces. The ability of the
bioadhesive to degrade with time as the tissue heals is important. However, the adhesive
needs to maintain its mechanical integrity for a period of time immediately after surgery
to prevent premature rupture of the repaired tissue. Degradation byproducts must be noncytotoxic and, ideally, an adhesive should support rapid native cellular ingrowth and gene
expression to regenerate functional tissue.

1.3 ROS production from Catechol adhesive
Catechol (1,2-dihydroxy benzene) is an organic compound that is commonly found in the
DOPA molecule, which is secreted by mussel along with mussel adhesive proteins. In a
8

synthesis polymer preparation, dopamine moiety is commonly used to impart the catechol
functionality onto various polymer backbones (i.e., polyacrylamide, PEG), resulting in
the synthetic adhesive, which can perform under wet condition. However, the process
gelation and crosslinking of such adhesive required periodate chemistry or other types of
oxidants to facilitate the oxidation process of the catechol moiety (Figure 3). Catechol
oxidized into quinone in the presence of O2 resulted in superoxide formation leading to
more oxidization of catechol through superoxide mediated oxidation. The superoxide
mediated oxidation then oxidizes catechol to quinone but no longer generate superoxide
but hydrogen peroxide instead. Since superoxide can also interact directly with protons,

Figure 3. NaIO4-mediated catechol oxidation to quinone and crosslinking. ROS, such as
superoxide (O2˙‒) and hydrogen peroxide (H2O2), are generated during the process. R =
PEG polymer
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more H2O2 and O2 can be generated as a result. This chemical reaction loop will continue
until no catechol is left to be oxidized. Since H2O2 half-life is significantly longer (hours
vs. seconds) than those of superoxide, H2O2 is the main species of interest to control in
order to tailor the biological response from catechol based adhesive36.

1.4 H2O2 and its biological functions
H2O2 is a chemical substance that promptly used within living cells. It is known to govern
many critical biological functions through the participation in oxidative biosynthesis
functions in cells. Additionally, there is evidence pointing that cells exhibit a
concentration-dependent response to H2O2 (Table 1.). At low concentration, it plays a
crucial role as a signaling agent between cells. At an elevated concentration, it was
observed to be serving as a defense mechanism for foreign invaders or kick start the
inflammatory response. At a high concentration, H2O2 can break down biological tissues
and denature proteins. H2O2 was utilized in biomedicine since the 1800s as biocidal agent
37

. Recently, H2O2 (100 µM) was utilized not for their biocidal purposes but for wound

lysate, induced angiogenesis, and allows new tissue growth 38. However, actively remove
H2O2 by catalase enzyme delayed wound healing as eschar formation is disrupted. On the
other hand, a higher dose of H2O2 (≥ 105 µM) retarded the wound healing and form a
chronic wound as oxidative damage was done. However, at this concentration, H2O2 can
achieve bacteriostatic

39

. H2O2 concentration should be at least 106 µM in order to

function as a bactericide agent 40. Sustaining release of H2O2 (10-103 µM) from ascorbate
acid selectively kill cancer cells but leave normal cells live41. More recently, a large dose
10

of 1 M was shown to completely kill both gram-positive and gram-negative bacterial as
well as to deactivate both enveloped and non-enveloped virus42. Thus, the H2O2
concentration can be modulated to show different functions matched different
applications and desired biological responses.

Table 1. H2O2 concentration and their correlated biological effect
[H2O2] (µM)

Biological Effect

Actively remove

Delayed dermal wound healing

102

Delayed tenocyte proliferation

102-103

Accelerate dermal wound healing

103

Bacteriostatic (E. coli)

105

Delayed dermal wound healing

106

Biocide and virucide

Sustain release of 101-103

Kill cancer cells but safe for healthy cells

11

1.5 H2O2 degradation and control method.
H2O2 degradation was done naturally within a living organism through the use of catalase
enzyme. The enzyme is highly efficient and can break down H2O2 into H2O and O243.
Catalytic degradation of H2O2 can also be achieved with a metal catalyst. Platinum,
palladium, and iron are among the examples of metal groups that can catalytically
breakdown H2O244,

45

. However, metalloid oxides, SiO2, was also found to be able to

break down H2O2 in a similar manner to those of the metal oxides44. The degradation rate
of H2O2 with SiO2 was reportedly slower by at least an order of magnitude (when
compare to AIO3) to up to 3 order of magnitude ( when compare to ZrO2) when
compared to other conventional metal and ceramics44. Decomposition is not the only
mean of control for silica over H2O2, however. Multimember complexation between
H2O2, SiOH, and H2O was reported as a stable complexation which allows for a
reduction in measurable H2O246,

47

. The absorption was reported as reversible, which

would allow the adsorbed H2O2 to participate in catalytic decomposition as the molecule
of H2O2 are in close proximity of the silica-based material surface.

1.6 Silica particle as reinforcement and bioactive additives
The incorporation of inorganic nanoparticles (NP) into polymeric matrices provides a
simple approach to create nanocomposites with improved mechanical properties and
tailored biological responses

48, 49

. This reinforcement strategy of using NP to form

physical and chemical crosslinks within a polymer network has been rigorously studied in

12

the past decades. Specifically, nanoparticles used in biomedical applications include
silica (Si) particle, bioactive glass, and hydroxyapatite

48, 50-52

. Among these particles, Si

particles are one of the most commonly used, with key examples such as magnetoluminescence composites
mechanical property

49, 55

53

, drug-releasing composite

54

, and composites with elevated

. Additionally, Si NP degrades into silicic acid, which has been

found to be beneficial for bone and connective tissue formation and remodeling 56, 57.
Despite the advantages associated with Si NP, some reported the toxicity of these
particles due to its reduced size

56, 58, 59

. The cytotoxicity of NP is associated with the

direct physical interaction between the particle and cell membrane, resulting in the
cellular internalization of NP

60

. Particles with a larger size exhibited reduced

cytotoxicity, as the internalization process is hindered when the particle size approaches
micron scale 56, 58, 59, 61. However, the performance of the micron-sized particle is inferior
to that of NP in improving the mechanical properties of polymer matrices, due to a
significant reduction in the surface area as well as the limitation in particle dispersion
63

62,

. To overcome the cytotoxicity associated with NP and the reduced performance of

micron-sized particles as a filler, we prepared clustered microparticles (MP) that were
formed through the clustering of NP. We hypothesized that the clustered MP would have
reduced cytotoxicity due to its increased size while retaining nano-scaled surface features
with an enhanced surface area for interacting with the polymer matrix (Scheme 1).
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Scheme 1. Schematic representation of the chemical interactions involved in the curing
and adhesion processes of the composite adhesive. PEG-DA contains catechol endgroups that can interact with silica nano- and microparticles (NP and MP, respectively)
through strong reversible interactions (A). Oxidation of catechol in the presence of
NaIO4 forms highly reactive quinone, which results in catechol polymerization and curing
of the adhesive (B), as well as the formation of an interfacial covalent bond with
nucleophilic function groups (i.e., –NH2 of lysine) and adhesion to the surface of soft
tissue (C). Reproduced from reference 64 with permission from IOP Publishing copyright
2020.

1.7 Statement of purpose and experiment set-up
Mussel inspired catechol-based adhesive has gained popularity in research in recent
years. However, only recently that our group has identified the byproduct to be singlet
oxygen, superoxide, and H2O2. It is crucial to understand their biological responses and
able to has reasonable control over such a byproduct. H2O2 are the most stable reactive
14

oxygen species among all aforementioned all byproduct, and its biological effect is well
understood. The concentration-dependent biological response of the H2O2 allows the
unique approach in material design to take shape. Depending on the concentration and the
exposure time, H2O2 can cause a variety of cellular and tissue responses ranging from
accelerated wound healing (tissue-specific, ranging from 10-103µM) to tissue
denaturation (>104µM). Therefore, H2O2 concentration can be modulated to fit different
types of tissues and applications. One way of controlling hydrogen peroxide is through
the use of silica particles. We first investigate and master our capability in controlling the
particle synthesis before chemically altering the surface chemistry of the particle. Then
the particle was subjected to complexation tests with H2O2 to determine their efficiency
and affinity toward H2O2 control. We then study the use of silica particles as a modulator
for H2O2 byproduct in the form of composite additives. The composite then subject to
physical (i.e., gelation, rheometry, lap shear), chemical (i.e., Fourier Transform Infrared
Spectroscopy, stability test), and biological (i.e., in vitro cell response) tests to determine
and confirm the expected changes with the focus on the biological response. H2O2-Silica
particle complexation was found to be a viable option not only for the reduction of H2O2
but also for the unique property of highly hydrophilic silica particles, which allows the
release of soluble silica out of the composite adhesive. The first approach for silica
nanoparticle incorporated catechol-based bioadhesive was studied as a feasibility material
model. The composite adhesive was utilized to evaluate the extent of control over H2O2
concentration and cellular responses. The study is also used to confirm that the addition
of silica particles will not hinder the main function of the adhesive, which are remaining a
15

strong adhesive. Polyethylene glycol is selected as the backbone material because it has
been approved by the FDA and was used in many applications, including cell
encapsulation

65

, scaffolding66, and drug delivery67. Silica was thought to be bioinert or

cytotoxic. However, recent understanding shines a new light on the material. Crystallinity
59

, size

58

, and surface charge68 of the particle govern their reactivity with living cells.

Combing with PEG hydrogel, they are ideal biocompatible composite systems that the
biological responses to the hydrogel can be fully contributed to the H2O2 released during
catechol autoxidation and the resulting modulation of H2O2 from the particle. It is clear
from the previous study that adding particle alone has limited use when specific
applications required a higher concentration of H2O2 (i.e., antimicrobial, dermal wound
healing). As a result, the continuation study was utilizing the robust design of experiment
approach to predict and narrow down the formulation to be tested for, specifically,
dermal wound healing application. Full thickness wound model in mice was selected as
the model to study the effect of adhesive architecture, H2O2 concentration, and particle
incorporation on the wound healing process. With more flexible formulation selection,
silica particle role was changed from scavenger in the previous study into a complete
modulator allowing for the fine tuning of H2O2 to be achieved. Finally, the wound
healing response to the treatment of the adhesive and their composites were determined.

16

2 Synthesis, Modification, and Characterization of Silica
Particle and Catechol-Based Polyethylene Glycol Adhesive2
2.1 Synthesis, Modification, and Characterization of Silica Particle

2.1.1

Understanding Silica Particle and Their Biological Effect

Two of the most commonly used silica precursors in both industry and research include
tetraethyl orthosilicate (TEOS), tetramethyl orthosilicate (TMOS), and sodium silicate
(Na2SiO3) or water glass

69-71

. All silica precursors produce the final product through the

process of hydrolysis and condensation of silicic acid precursors under catalysts resulting
in predominantly silicon dioxide product 72. Both acidic and basic conditions can be used
to catalyze the reaction as protonation of alkoxide can occur faster with the extra protons
from the acid species during the hydrolysis process (Figure 4)

70, 72

. However, the extra

protons in from the acid species also allow the interaction between silanol groups and
ethoxy groups to occur, slowing down the condensation process. Ultimately, the
condensation between the silanol groups or between silanol groups and ethoxy groups
creates siloxane bridges (Si–O–Si) that form the entire silica structure

72

. The inverse

relationship is true for the basic catalytic reaction. Hence, the acid catalyst will result in

2

Parts of the content in this chapter was published in Biomedical Materials, 13(2), p.025003.Copyright
2020 American Chemical Society. https://iopscience.iop.org/article/10.1088/1748-605X/aa985d/meta
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fast hydrolysis and slow condensation. Inversely, the basic catalyst will result in slow
hydrolysis and fast condensation.
The main difference between all silica precursors is the rate of chemical conversion,
which results in differences in the rate of silica product formation through hydrolysis and
other preparation methods (i.e., pyrolysis, acid precipitation, etc.) (Figure 4)

72, 73

. For

instance, TMOS demonstrated to be around four times faster hydrolysis rate when
compare to TEOS is an alkoxy preparation method 72, 73.
TEOS and TMOS are effective silica precursors with generally higher than 90% recovery
rate of silica product by weight when preparing through hydrolysis and more than 70%
recover rate by weight when pyrolytically preparing through flame spray pyrolysis
process (FSP)72, 74. FSP is the most commonly utilized method to produce silica on an
industrial scale as there are no solvent and separation required to retrieve the final
product

73

. However, Na2SiO3 is more commonly used, and the resulting silica particle

prepared from the FSP method has high crystallinity as high heat exposure is required for
such synthesis method 75.
Crystallinity is found to be one of the deciding factors in utilizing silicon-based particle
as crystalline particle both synthetic (silica nanocrystals) and natural (i.e., mica, asbestos,
and silicon fume) are all found to cause cell apoptosis and can leads to tissue
degeneration especially in epithelium cells and respiratory tracts

58, 59

. Additionally,

crystallinity is also directly governing the mode of which the particle causes a biological
response from highly toxic to cells to nearly biocompatible with higher crystallinity
18

resulting in higher toxicity

58, 64

. It is also a deciding factor whether the particle can be

biologically degraded through hydrolysis as the lower

A

B

Figure 4. Basic-catalyzed silica hydrolysis and condensation (A) and acid-catalyzed
silica hydrolysis and condensation. Reprint from ref. 71 and 69, with permission from
Elsevier copyright 2020 and The Royal Society of Chemistry, respectively
19

crystalline particle can partially degrade through hydrolysis before being ingested by the
cells

54, 56, 59, 76

. There are studies suggested that the degraded product of the amorphous

silica particle is silicic acid, which can contribute to increased cell proliferation and cell
migration

56, 76

. As a result, most research in biomedicine, when utilized silica-based

materials, are willingly lowering crystallinity with a compromise on the use of solvent
and separation technique to ensure an improved biological response.

2.1.2

Stӧber Synthesis Method

In 1968, Werner Stöber and his research team had reported a new approach in
synthesizing particulate in an aqueous reactor with ammonia as a catalyst to control the
hydrolysis and condensation kinetics of ethoxy silane in alcohol

70, 77

. The resulting

product is a fine powder of uniform silica particles (Scheme 2). For Stӧber synthesis,
morphological and size distribution controlled are the main benefit of getting from the
synthesis method. The key synthesis methods derived from Stӧber finding may include
Bogush and Zukoski

74

. The investigation of factors that affect the particle formation in

this synthesis method may include a selection of silica precursors, the use of surfactant,
application of shear force, pH, and temperature of the reactor solution70, 72, 78, 79. These
factors are not only affecting the final product, the particle but also affect the reaction
speed, separation method, purification method, etc. The modified Stöber method utilized
the understanding of these factors and modified the synthesis setup, so the researcher has
more control than the initial concept proposed by Stӧber and his colleagues.
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Scheme 2. representation of simplified Stöber synthesis. Reproduce from Ref.

70

with

permission from Elsevier copyright 2020

2.1.3

Exploratory Experiment on Modified Stӧber Synthesis Method

2.1.3.1 Material
Tetraethyl orthosilicate (TEOS, 99.8%), methanol, ethanol (200 proof), potassium
hydroxide (pallet, 85%), sodium hydroxide (NaOH, 50% w/w), cetrimonium bromide
(CTAB, 99.9%), acetic acid (CH3COOH, glacial 98%), and hydrochloric acid (HCl,
37%) were purchased from Fisher Scientific (Pittsburgh, PA).
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2.1.3.1 Method
The synthesis setup consisted of a hot plate stirrer with digital temperature and speed
indicator (Fisher Scientific), Erlenmeyer flask with appropriate volume (100-500 ml), a
glass flask adapter (24/40), and rubber caps. A glass reflux column setup was utilized
during the purification and surface modification to contain escaping acidic fume
(Figure5). Aluminum foil was used to create a localized heat radiator to improve
temperature management. For the basic catalyst experiment, 12.5 ml of NaOH was added
to 250 ml of ethanol/deionized water mixed solution (1:1 v/v) under vigorous stir to
create a basic reactor solution. For the acid catalyst experiment, 20 ml of HCl was added
to 250 ml of ethanol/deionized water mixed solution (1:1 v/v) under vigorous stir to
create an acid reactor solution. 9.7 ml of TMOS and 10.6 ml of TEOS (1g) was added to
the reactor solutions dropwise. The mixed solution was allowed to react for 1 or 12 hours
before the solution was collected and filtered through a paper filter with a pore size of 40
µm to remove large contaminants and aggregates. The filtered solution was then
transferred to a centrifuge tube. Ultracentrifugation (10000 Gs) was utilized to collect the
particle. The filtered solution was centrifuged for 15 minutes; then the supernatant was
discarded. The particle was then resuspended in 40 ml deionized water to remove residual
acid or base. The purification was repeated three times. The resulting particle was then
dried under vacuum for 48 hours before weighting to fund the recovery rate. The
recovery rate was calculated via the following equation:
%R = 100×W1÷0.461
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(1)

Where %R is the recovery rate of the particle, and W1 is the weight of the dried particle.
0.461 was derived from the precursor silica conversion as 1 g of silica precursor would
result in 0.461 g of SiO2 with 100% conversion efficiency

Figure 5. Equipment setup for silica particle surface modification. Yellow box indicates
the flask convertor and reflux column connection

Table 2. Exploratory silica particle synthesis condition
Silica

Condition

Time (hours)

Precursor
TMOS

Approx. Recovery
(%)

pH 1 25oC 400 rpm

1

23

30

12

66

1

75

12

84

1

12

12

65

1

64

12

77

pH 11 25oC 400 rpm

o

pH 1 25 C 400 rpm
TEOS
o

pH 11 25 C 400 rpm

The results indicated that TMOS is a more efficient silica precursor as it can form silica
particles more rapidly when compared to TEOS (Table 2). However, TMOS produced a
higher amount of aggregates as well as was found to generally be harder to control
morphology and size 80, 81. As a result, TEOS was selected to be the main silica precursor
in this study.
As a continuation in particle synthesis, nonporous silica nanoparticle (NSi) was prepared
using a modified Stöber method without surfactant

64

. The silica precursor solution was

prepared by mixing 4 g of TOES with 50 mL of ethanol and sonicated for 10 minutes.
The reactor solution was prepared with 25 mL deionized water mixed with 30 mL ethanol
and vigorously stirred (15 minutes at 400rpm) using a hot plate stirrer at 75oC. The pH of
the reactor solution was maintained at pH 11 by adding 0.1 M NaOH. The silica
24

precursor solution was added dropwise into the reactor solution at a rate of approximately
300 µl/second while stirring at 400 rpm. The solution turned milky white immediately
after the precursor have been added to the reactor solution. After stirring for 1 hour at 75
o

C, the pH of the reaction mixture was neutralized by adding 0.1 M acetic acid. The

reaction mixture was further stirred for an additional 12 hr at room temperature. The
reaction mixture was filtered using a filter paper with a mesh size of 20 µm to remove
large contaminants. Ultra-highspeed centrifugation (10000 Gs) was used to separate the
particles from the solution. The particles were washed vigorously three times with
ethanol to ensure complete dehydration and removal of sodium acetate. After drying
under a vacuum of 24 hrs, the yield of NP was 1.5 g. Mesoporous silica particles with
low (LSi) and high (HSi) porosity were prepared using the same Stöber method with
CTAB as a surfactant. The silica precursor solution was prepared by mixing 0, 9.4, or
18.8 g of CTAB (for NSi, LSi, and HSi, respectively) into 500 ml of ethanol and water
mixed solution (2:1 v/v ratio) and vigorously stirred (15 min at 400 rpm) at 55 °C via a
heating manifold and pH 11 by adding 0.1M NaOH dropwise. Then, 10 ml of TEOS
solution was added dropwise into the reaction solution at a rate of approximately 300 μl
s−1 while stirring at 1000 rpm. The mixed solution was left stirring for 1 hour at 55 °C
and pH 11, then the heating manifold was removed, and the pH of the reaction mixture
was neutralized by adding 0.1M HCl dropwise. The mixture was further stirred for an
additional 15 minutes at room temperature. The reaction mixture was centrifuged at
10,000 kGs then washed three times with methanol, ethanol, and deionized (DI) water.
The particles were dried under vacuum for 24 hours and sifted using American Society
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for Testing and Materials (ASTM) 450 (32 μm) sifters to remove any large contaminants
and aggregates. The yield of the NSi, LSi, and HSi particles was 75%, 68%, and 66%,
respectively.

2.1.4

Surface modification

Silica and silicate surface modification can easily be done with various chemicals (i.e.,
acid and alkaline treatment), mechanical (mechanical abrasion), and physical treatments
(i.e., increase temperature). Here we will specifically discuss chemical treatment of the
silica surface to produce hydroxide sites on the silica surface
The chemical treatment on silica surface are widely used in electronics and industry
during cleaning and activating the surface for further modification with silane coupling
chemistry. However, most of the cleaning and surface treatment techniques require the
use of strong alkaline treatment (i.e., potassium hydroxide (KOH), sodium hydroxide
(NaOH)), strong acid treatment (i.e., hydrogen fluoride (HF)). These are highly
hazardous materials which require special handling and disposal as they are highly
corrosive and reactive with water. Exploratory experiments were done to functionalized
the surface of silica particle synthesized from the previous section with strong alkaline.
However, the total loss of material was observed (Table 3). The treatment was done with
100 mg of HSi particle in 5 ml of KOH, NaOH, and HCl solution under a vigorous stir. A
borosilicate glass reflux column was used with the experiment with a heated solvent to
prevent alkaline fume escapes. The solution was left stirring at 400 rpm at room
temperature or at 95 oC. After 0.5 or 6 hours, the solution was then allowed to cool down
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to room temperature then be transferred to a centrifuge tube. Ultracentrifugation (10000
Gs) was used to collect the particle. The centrifugation was done for 15 minutes, then the
supernatant was discarded, and the particle was resuspended in 40 ml deionized water.
The resuspended solution was then centrifuged to remove residual acid or base from the
particle, repeating three times. The purified particle then dried under vacuum for 48 hours
before being weight again to determine the recovery rate. The following equation was
used to calculate the recovery rate in percent:
%R = 100×W1÷W0

(2)

Where %R is recovery rate in percent, W1 is the weight of the particle after treatment, and
W0 is the initial weight of the particle
Table 3. Exploratory surface modification condition
Reactor

Concentration

Time

Temperature

(hours)

Approx.
Recovery

0.5

25

<40%wt

6

95

Loss

0.5

25

Loss

6

95

Loss

0.5

25

<20%wt

0.1 M (pH 13)
KOH
1 M (pH 14)

NaOH

1 M (pH 13)

27

6

95

Loss

0.5

25

Loss

6

95

Loss

0.5

25

94%

6

95

87%

0.5

25

95%

6

95

85%

10 M (pH 14)

0.1 M (pH 1)
HCl
1 M (pH 0)

The recovery rate was found to be low, and the separation was found to be poor as the
resulting particle are presumably lost a large amount of mass and integrity with the strong
alkaline treatment. As an alternative, weaker acid has been utilized in place of a strong
acid with elevated temperature. HCl treatment was found to mildly affect the particle
recovery and deemed suitable for surface modification of the nanoparticle. This is further
supported by the fact that silica material has an isoelectric point at around pH 2, as shown
in Figure 6. Lower and higher pH value allows the dissolution of silica to occur at
various speed. The dissolution kinetics of silica was found to be the highest in the
alkaline range (pH>10) and, though significantly lower, highly acidic condition for the
acidic range (pH<3). The HF treatment was never attempted as it is generally known that
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HF reacts more violently to glass than KOH as well as the special hood is required to
safely handle HF.

Figure 6. Effects of pH value on the silica condensation rate, charge properties, and
charge density on the surface of the silica species. Reproduced from Ref. 72 with
permission from The Royal Society of Chemistry.

2.1.5

Characterization methods

The most important aspect of utilizing Stӧber method is to ensure minimal crystallinity
and the ability to effectively control the size and morphology of the resulting particle.
The particle characterization method is divided into two approaches, which generally
include physical and chemical analysis. The particle chemical properties are usually
determined with simple FTIR analysis to ensure the presence of Si-O-Si, Si=O, and Si29

OH. The FTIR is also utilized to ensure the efficacy of the purification method as well.
The physical properties of silica particles are generally involved in morphological
analysis and size distribution analysis. This is to ensure that the particle size and
morphology are consistent among the sample group. X-ray diffraction was used to ensure
the amorphous nature of the particles (Figure 7). There were no definitive peaks that are
correlated with the crystalline SiO2 standard.

The results indicated that all particles

prepared with the modified Stӧber method are amorphous regardless of the use of
surfactant and surface modification.

Green = HSi
Pink

= AHSi

Orange = LSi
Blue

= NSi

Figure 7. XRD spectra of HSi, AHSi, LSi, and NSi. Pink markings indicate correlated
crystalline SiO2 crystal spectra, cristobalite
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3 Controlling the Release of Hydrogen Peroxide from
Catechol-Based Adhesive Using Silica Nanoparticle3
3.1 Abstract
Catechol-based bioadhesives generate hydrogen peroxide (H2O2) as a byproduct during
the curing process. H2O2 can have both beneficial and deleterious effects on biological
systems, depending on its concentration. To control the amount of H2O2 released from
catechol-containing polyethylene glycol-based adhesive (PEG-DA), the adhesive was
formulated with silica nanoparticles (SiNP) prepared with increased porosity and acid
treatment to increase Si-OH surface content. These SiNP demonstrated increased surface
area, which promoted interaction with catechol and resulted in increased cure rate, bulk
mechanical properties and adhesive properties of PEG-DA. Most importantly, SiNP
demonstrated a 50% reduction in the released H2O2 while improving the cell viability and
proliferation of three primary cell types, including rat dermal fibroblasts, human
epidermal keratinocytes, and human tenocytes. Additionally, SiNP degraded into soluble
Si, which also contributed to increased cell proliferation. Incorporation of porous and
acid-treated SiNP can be a useful approach to simultaneously modulate the concentration
of H2O2 while increasing the adhesive performance of catechol-based adhesives.

3

This article was just accepted in ACS Biomaterials Science & Engineering. Copyright 2020 American
Chemical Society. https://pubs.acs.org/doi/abs/10.1021/acs.biomac.7b01311
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3.2 Introduction
Mussels adhere strongly to various surfaces under wet conditions through the secretion of
adhesive proteins that solidify to form adhesive plaques

16

. Catechol moiety found in

mussels adhesive proteins (MAPs) is one of the main contributors to the interfacial
binding and crosslinking capabilities of these proteins

82

. Catechol-modification of

natural and synthetic polymers is widely used to create in situ curable bioadhesives with
strong, wet adhesive properties 83, 84. To activate catechol for crosslinking, catechol needs
to be oxidized into its reactive quinone form by chemical-mediated (i.e., periodate) or
enzymatic (i.e., peroxidase) oxidation

85, 86

. This is a critical step to initiate cohesive and

interfacial crosslinking of catechol-containing adhesive. Specifically, periodate is one of
the most commonly utilized oxidants for initiating curing of injectable biomaterials

87-89

.

Recently, our lab reported that hydrogen peroxide (H2O2) is generated as a byproduct
during the oxidative crosslinking and curing of catechol-containing adhesive

40

. The

generated reactive oxygen species (ROS) contributed to localized in vitro cytotoxicity,
promoted antioxidant enzyme expression in primary dermal and tendon fibroblasts, and
promoted M2 macrophage polarization when the adhesive was implanted subcutaneously.
Living organisms naturally generate H2O2 as a part of normal wound healing and
inflammatory response

90-92

. The effect of H2O2 on biological systems is also highly

concentration-dependent. Application of H2O2 at micromolar ranges have been shown to
accelerate dermal wound healing

93, 94

. Additionally, H2O2 is a natural disinfectant

39

.

However, high levels of H2O2 can destroy healthy tissues, lead to chronic wounds, retard
32

natural healing cascade, and induce tumor formation

38, 95

. Given the varying H2O2-

associated biological responses, there is a need to tune the amount of H2O2 released from
catechol-containing biomaterials according to the application-specific material design.
H2O2 concentration can be controlled through the use of catalytic metal oxides
(Al2O3,TiO2), metal ions (Fe3+, Mn2+, and Cu2+) and enzymes such as catalase

40, 45, 96

.

However, most catalytic metal oxides and ions are not suitable for biological applications
due to their cytotoxicity, and toxic metal accumulation can occur with prolonged
exposure

68, 97

.

Although catalase readily decompose H2O2 and are suitable for

biomedical applications, they are limited by elevated costs and issues with stability

98, 99

.

As an alternative, silica (Si) particles and silicate material are economically viable and
can degrade H2O2 44. Si materials are more biocompatible when compared to other metal
oxides 97. Additionally, H2O2 forms a multimember ring complex with Si-OH groups on
the surface of Si-based material in the presence of water, which helps to further stabilize
the complex 100, 101. However, Si material decomposes H2O2 at a significantly slower rate
when compared to other metal oxides

44

.Since both degradation and complexation of

H2O2 on Si material are surface dependent phenomena, a combination of increased
surface area and surface modification techniques can potentially improve the efficiency
of silica particles for H2O2 degradation.
In this work, we prepared highly porous Si particles and further treated these particles
with strong acid to create a Si-OH-rich surface. We hypothesize that the combination of
increased surface area and surface chemistry modification can be utilized to modulate the

33

release of H2O2 from the catechol-containing adhesive (Scheme 3). A branched 8-armed
PEG with terminal dopamine moieties (PEG-DA) was used as the model adhesive

64

.

Dopamine resembles the amino acid, DOPA, found in MAPs and contains the catechol
side chain needed for oxidative crosslinking and interfacial binding. PEG-DA was
combined with the porous Si particles to form a composite adhesive and the effect of
particle incorporation on the release of H2O2, the material property of the composite
adhesive, and the cellular response of primary fibroblast, tenocyte, and keratinocyte was
investigated.

Scheme 3. Schematic Representation of Mixing PEG-DA with Porous Si Particles to
Form a Composite Adhesive (A); Catechol Generates H2O2 During Oxidative
Crosslinking (B); Surface Si–OH Forms Complexation with H2O2 and Water, Resulting
in H2O2 Degradation (C)
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3.3 Materials and methods

3.3.1

Materials

Phosphate buffer saline (PBS), tetraethyl orthosilicate (TEOS, 99.8%), methanol, ethanol
(200 proof), sodium hydroxide, cetrimonium bromide (CTAB, 99.9%), hydrogen
peroxide solution (H2O2, 30%), dimethyl sulfoxide (DMSO), and hydrochloric acid (HCl,
37%) were purchased from Fisher Scientific (Pittsburgh, PA). Sodium periodate (NaIO4,
>99.8%) was purchased from Acros Organics (Fair Lawn, NJ). Pierce Quantitative
Peroxide Assay Kit with sorbitol (ferrous oxidation-xylenol orange (FOX) assay), fetal
bovine serum (FBS), and Penicillin–Streptomycin (10 U/ml) were purchased from
Thermo Scientific (Rockford, IL). Rat primary dermal fibroblasts (RDF) were purchased
from Cells Biologics (Chicago, IL). Dermal Cell Basal Medium, keratinocyte growth kit,
primary human tenocytes (HT), and primary human epidermal keratinocytes (HEK) were
purchased from ATCC (Manassas, VA). TransWell® Permeable Supports (12 mm insert,
12 well plate, 3.0 μ, polycarbonate membrane) were purchased from Corning Costar
(Pittston, PA). Dulbecco’s modified Eagle’s medium (DMEM; with 4.5 g/L glucose and
glutamine, without sodium pyruvate), and trypsin–EDTA (0.05% Trypsin/0.53 mM
EDTA in Hank’s balanced salt solution) were obtained from Corning Cellgro (Manassas,
VA). Tenocyte Growth Medium was purchased from Zenbio (Research Triangle Park,
NC). Polyfreeze®, phosphate-buffered saline (PBS, BioPerformance certified, pH 7.4),
bovine liver catalase, Trichrome Stain (Masson’s) Kit, Bouin’s solution, and Weigert’s
iron hematoxylin solution were purchased from Sigma-Aldrich (St. Louis, MO). 3-(4,535

dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 98% (MTT) was purchased from
Alfa Aesar (Ward Hill, MA). Anti-Ki-67 antibody (ab15580), goat anti-rabbit IgG H&L
(Alexa Fluor 488) (ab150077), and goat anti-rabbit IgG H&L (Alexa Fluor 647)
(ab150079) were purchased from Abcam (Cambridge, MA). 4,6-Diamidino-2phenylindole (DAPI) was obtained from Invitrogen (Grand Island, NY). PEG-DA was
prepared following previously published protocols using an 8-armed PEG (MW=20 kDa,
JenKem USA, TX) 64

3.3.2

Synthesis of Silica Particles

Nonporous silica nanoparticle (NSi) was prepared using a modified Stöber method
without surfactant 64. Mesoporous silica particles with low (LSi) and high (HSi) porosity
were prepared using the same Stöber method with CTAB as a surfactant. The silica
precursor solution was prepared by mixing 0, 9.4, or 18.8 g of CTAB (for NSi, LSi, and
HSi, respectively) into 500 ml of ethanol and water mixed solution (2:1 v/v ratio) and
vigorously stirred (15 min at 400 rpm) at 55 °C using a heating manifold and maintained
at pH 11 with dropwise addition of 0.1M NaOH. Then, 10 ml of TEOS solution was
added dropwise into the reaction mixture at a rate of roughly 300 μl s−1 while stirring at
1000 rpm. The mixture was left stirring for another hour at 55 °C. 0.1 M HCl was added
dropwise to the reaction mixture to neutralize its pH, which was further stirred for
another 15 minutes at room temperature. The reaction mixture was centrifuged at 10,000
kGs then washed 3 times with methanol, ethanol, and deionized (DI) water. The particles
were dried under vacuum for 24 hours and sifted using American Society for Testing and
36

Materials (ASTM) 450 (32 μm) sifters to remove any large contaminants and aggregates.
The yield of the NSi, LSi, and HSi particles was 75%, 68%, and 66%, respectively.

3.3.3

Silica Particle Modification

Acid-treated HSi (AHSi) particles were prepared using a modified version of a previously
developed acid activation technique

79

. HSi (1 g) was resuspended in 200 ml of ethanol,

then 2 ml of 12 M HCl was added into the mixture. The mixture was heated at 90 oC with
continued stirring under a N2 environment with a reflux column for 12 hours. NaOH
(17.6M) was added dropwise to neutralize the solution pH to 6.5 and then was further
stirred for 30 minutes at room temperature. The mixture was centrifuged at 10,000 kGs at
4oC, and the particles were washed 3 times with methanol, ethanol, and then DI water.
The particles were dried under vacuum for 24 hours and sifted through ASTM 450 (32
μm) sifters. The yield of these particles was approximately 33%. The particles were
dehydrated in a 200°C oven over a bed of potassium carbonate desiccant for 12 hours
before backfilling with N2 gas to remove all moisture.

3.3.4

Silica Particle Surface and Composition Characterization

The total surface area of the particle was calculated using the Brunauer-Emmett-Teller
(BET) model. A BET surface area Micromeritics ASAP 2000 sorptometer
(Micromeritics) was utilized to measure the surface areas of silica particles by nitrogen
adsorption at liquid-nitrogen temperature (-196.15oC). The samples were degassed at 120
°C for 12 hours before the surface measurement. The total surface area was determined
37

by the physical absorption of N2 gas on to the particle surface

102

. A FEI 200kV Titan

Themis. Scanning Transmission Electron Microscope (S-TEM) was used to visualize the
morphology of the particle, and Energy-dispersive X-ray spectroscopy (EDS) was used to
measure the elemental (Si and O) content of the particle. ImageJ program (NIH) was used
to measure the particle size from TEM images.

3.3.5

Adhesive Formation

The PEG-DA adhesive hydrogels were prepared following a previously published
protocol 64. The adhesive was prepared by mixing equal volume of the adhesive precursor
solution (300 mg ml−1 of PEG-DA in 2xPBS at pH 7.4) and NaIO4 solution (54.5 mM in
DI water). The final concentration of PEG-DA was 150 mg ml−1. The Si particle
incorporated composite adhesives were formed in a similar manner with the addition of
20 wt% of the corresponding Si particles into the PEG-DA precursor solution. The final
concentration of the particles in the composite adhesive was 10 wt%. The final NaIO4 to
dopamine molar ratio was 0.5 for all adhesive formulations. To determine the gelation
time of the hydrogels, 200 μl of the mixed solution was introduced into a 1.5 ml
scintillated vial. The time it took for the mixture to cease flowing in a tilted vial was
determined as the cure time 27. Unless specified otherwise, the adhesive was cured in
between two borosilicate glass sheets with a silicon rubber mold (width = 4 cm, height =
4 cm, thickness = 1.5 mm) for 24 hours. The cured adhesive sheet was cut into disk
shapes using a tissue punch with a diameter of 10 mm to create hydrogel disks with a
diameter of 10 mm and a thickness of 1.5 mm. The hydrogel disks were further
38

equilibrated in PBS (pH = 7.4) before additional characterization. Adhesive formulations
containing NSi, HSi, and AHSi are denoted as PEG-NSi PEG-HSi and PEG-AHSi,
respectively.

3.3.6

Physical and Chemical Characterization of the Adhesive

Samples were freeze-dried for at least 48 hours and characterized using Fourier transform
infrared (FTIR) spectroscopy (Perkin Elmer Spectrum One with DLATGS detector) with
a single bounce attenuated total reflectance (ATR) unit (PIKE Technologies, diamond
internal reflection element (IRE) GladiATR). The scan rate was set at 800 scans/minutes
with a resolution of 1 cm-1. The FTIR experiments were done at ambient conditions. In
vitro degradation behavior of adhesive disks (n = 3) was determined by incubating the
samples in 5 ml of PBS (pH = 7.4) at 37 °C and tracking their remaining mass (Mr) over
8 weeks. The hydrogel discs were equilibrated overnight before the degradation
experiment started to ensure stable initial weight. The discs were then dried under
vacuum for at least 48 hours. Dry weight was used to determine the degradation rate
using the following equation:

(3)

where M0 and Mt are the initial mass of the adhesive and its mass after incubation for a
given amount of time, respectively 86. The PBS solution was replaced every 7 days.
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To determine the concentration of soluble silica released from the adhesive, fully cured
samples (n = 3 for each group) were incubated in 1 mL of 1xPBS (pH 7.4) in a
polystyrene container for 2 weeks. The PBS extracts were diluted by adding deionized
water to 10 mL in a polystyrene centrifuge tube prior to testing. The diluted extract was
then evaluated for silica content using inductively coupled plasma optical emission
spectroscopy (ICP-OES; Perkin Elmer Optima 7000DV) utilizing a cross-flow nebulizer
(plasma 15 mL min-1, auxiliary 0.2 mL min-1, nebulizer 0.80 mL min-1, RF power 1,350
W, pump speed 1.5 ml min-1) Instrument Calibration Standard 3 (Perkin Elmer) was
used to create the calibration standards. Three samples per formulation were collected
and each sample was analyzed three times.
An oscillatory rheometer (Discovery Hybrid Rheometer HR2; TA instruments, Newcastle
DE) was used to determine the storage (G′) and loss (G′′) moduli of the cured adhesive
samples. Strain sweep experiment was performed by subjecting disk-shaped samples (n =
3) to a strain of 0.01–100% at a frequency of 0.1 Hz using a parallel plate setup at
ambient temperature. The gap distance was set at 87.5% of the thickness of each
individual hydrogel, to ensure sufficient traction during the rheometry experiment. 1 ml
of pH 7.4 PBS was introduced around the composite adhesive to prevent dehydration.
Lap shear adhesion test was performed using bovine pericardium while following a
previously published protocol according to ASTM standard F2255-05

64

. Strips of

pericardium tissues (2.5 cm x 2.5 cm) were kept moist in PBS. 100 μl of PEG-DA
precursor solution and NaIO4 solution with and without Si particles were mixed in a

40

scintillated glass vial before being transferred on to the surface of the tissue. Another
piece of pericardium tissue was applied over the adhesive to create an adhesive joint
(overlapping area of 2.5 cm2), which was compressed with a 100-g weight for 15 min.
The adhesive joint was submerged in PBS (pH = 7.4) at 37 °C for overnight prior to
testing. A digital caliper was used to measure the dimensions of the overlapped area of
each adhesive joint before testing. The fixation of the tissue pieces on to the test stage
was done with serrated metal grips to ensure sufficient traction. An Electroforce®
machine (Bose Electroforce Group, MN) was used to pull apart the adhesive joint to
failure at a rate of 0.1 mm s−1. The adhesive strength was determined by the maximum
load divided by the initial overlapped area of the adhesive joint.

3.3.7

In vitro Cell Viability

The cell viability experiment was performed following a previously published protocol
with modifications

64

. A quantitative MTT assay was used to determine the relative

viability of cells exposed to the adhesives and their extracts, while following ISO 109935 guideline

103

. Microfiltration was utilized as a sterilization method. The PEG-DA

precursor solution and NaIO4 solution were filtered with a 0.2 μm polyethersulfone
syringe filter (VWR International, USA). The particles were sterilized using ethylene
oxide in a microcentrifuge tube. Adhesive extracts were prepared by forming hydrogel
discs (diameter =10 mm and thickness = 1.5 mm, n=3) as described above, followed by
incubating each disc in 1 ml of cell-specific culture medium for 24 hours at 37oC. RDF,
HEK, and HT were suspended in their cell-specific culture medium. Cell suspensions
41

were then added to a 96-well microculture plate at a density of 1,000, 2,000, and 2,000
cells/well, respectively. Varying amount of culture medium was added to each well to
maintain the culture medium volume of each well to 100 μl. The cells were incubated in a
humidified incubator (37 °C, 5% CO2) for 24 hours to obtain a confluent monolayer of
cells. A light microscope (Olympus, PA) was used to observe the monolayer to ensure the
confluence level. Then, the medium was replaced with 100 μl of the adhesive extract.
After incubation for 24 hours, the medium was removed and replaced with 50 μl of MTT
solution (1 mg ml−1 in pH 7.4 PBS) and further incubated for another 2 hours. After the
2-hour incubation, the MTT solution was replaced by 100 μl of DMSO to dissolve
formazan crystals. The absorbance of each well was measured at 570 nm (reference 650
nm) using a Synergy HT Multi-Mode Microplate Reader (BioTek, USA). The relative
cell viability was calculated by dividing the average absorbance value of the sample from
that of cells cultured in the culture medium after subtraction of the absorbance
background of untreated culture medium 6.

3.3.8

In vitro Cell Proliferation

All experiments were performed with a Transwell set up to ensure the continuous
exposure of the cells to the composite adhesive. Ki-67 and DAPI fluorescence staining
were performed to analyze the proliferation of cells exposed to the adhesive placed in
Transwell inserts. NaIO4 (160 μl) and sterile adhesive precursor solution (1:1 v/v) was
introduced into a circular silicone mold with a dimension of 10 mm x 1 mm. The mixed
solution was left to gel for 5 minutes before being transferred into Transwell inserts.
42

RDF, HEK, and HT were seeded into 12-well Transwell-compatible plates at a density of
5,000, 20,000, and 20,000 cells/well, respectively. The cells were incubated (37 °C, 5%
CO2) for 24 hours to obtain a 60-75% confluent monolayer of cells. A light microscope
(Olympus, PA) was used to observe the monolayer to ensure the confluence level. The
culture medium was removed before the Transwell inserts were introduced. Fresh
medium (1ml) was added. Transwell inserts were removed after 24 hours of incubation
along with the culture medium. Cells were fixed using a 1% paraformaldehyde solution
for 15 minutes and permeabilized using a 1% Tween20 solution. The solution was
removed, and the cells were washed with a treatment solution of 0.1% Triton X-100.
After the treatment solution was removed, the primary Ki-67 antibody solution (1:1,000)
was introduced and incubated at room temperature for 45 minutes before being washed 3
times by the washing medium for 5 minutes each. The washing medium was removed,
then Alexa Fluor 488 green fluorescence stain was introduced for 45 minutes before
being wash 3 times with the washing medium for 5 minutes each. The washing medium
was removed, and the DAPI solution (1:1,000) was introduced for 5 minutes before being
washed 3 times using the washing medium for 5 minutes each. The washing medium was
removed, and the cells were analyzed via fluorescence microscopy using an automated
microscope (EVOS, Fisher). Ki-67 positive cells and cell nuclei fluoresced green and
blue, respectively. The total cell counts were averaged from all 27 images of each
formulation.
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3.3.9

Statistical analysis

Statistical analysis was performed using SigmaPlot 14 software. One-way analysis of
variance (ANOVA) with Tukey’s HSD analysis and Student’s t-test were performed for
comparing means of multiple groups and two groups, respectively, using a p-value of
0.05.

3.4 Results and discussion

3.4.1

Characterization of Si Particles

S-TEM was used to determine the particle size and morphology of each type of silica
nano particle (SiNP) (Figure 8). NSi appeared dark with solid-like morphology. On the
other hand, LSi, HSi, and AHSi were prepared with a quaternary ammonium surfactant,
CTAB, and appeared lighter in color with porous structures. The particle size of NSi
averaged around 660.6±52.63 nm, which was larger when compared to the porous
particles (528.08±34.25 nm and 422.24±23.24 nm for LSi and HSi, respectively) (Figure
9). This result suggests that the incorporation of CTAB reduced the final particle size by
reducing the microbubble size in the reaction solution through surface energy reduction
72, 78

. In the case of AHSi, acid treatment did not significantly affect its particle size when

compared to HSi.
BET-N2 sorption measurement demonstrated that the addition of CTAB during synthesis
increases the total surface area of the particle (Figure 10). NSi exhibited the smallest

44

surface area (13.72±0.26 m2/g) among all the SiNP, while the porous SiNP exhibited an
order magnitude higher surface area (256.58±0.71, 327.45±5.51, and 386.75±5.19 m2/g
for LSi, HSi, and AHSi, respectively). CTAB and other surfactants introduce porosity
into the silica particle, creating a mesoporous particle as a result

72, 78

. With an increasing

amount of CTAB, the porosity increased as more porogen were introduced. Acid
treatment after particle synthesis also significantly increased the pore volume in AHSi.
The effect is directly linked to the removal of silicate groups from the particle surfaces as
colloidal silicates during acid treatment

104

. Hence, the newly exposed surface formed a

multitude of hydroxylated silica groups under acid treatment 104, 105. S-TEM EDS analysis
indicated that the composition of silica to oxygen ratio (S:O) decreased when HSi was
treated with acid. The higher oxygen (O) content in AHSi indicated an increase in
oxygen-silicon groups (i.e., Si=O, Si-OH, Si(OH)2, and Si(OH)3) on the surface of the
particle.
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A

B
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D

Figure 8. STEM images of non-porous silica nanoparticle (NSi) (A), porous silica
nanoparticle (LSi) (B), highly porous silica nanoparticle (HSi) (C), and acid-heat treated
highly porous silica nanoparticle (AHSi) (D). Scale bars are 50 nm.
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Figure 9. Particle size distribution of silica particles. * p<0.05 when compared to each
other.
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Figure 10. Surface area of Si particles determined using BET N2 sorption. *p<0.05 when
compared with each other.

3.4.2

Effect of Silica Particle on H2O2 Decomposition

100μM of H2O2 was mixed with each type of SiNP, and the change in the concentration
of H2O2 was evaluated using FOX assay (Figure 11). The concentration of H2O2 is set
to mimic the H2O2 concentration in skin tissue after an injury (50-100 µM)

106

. When

treated with NSi, the relative concentration of H2O2 decreased slowly and over 80% of
the initial amount of H2O2 remained even after 72 hrs of incubation. Increasing particle
porosity and acid treatment further decreased H2O2 concentrations (62.26±1.05 and
35.12±4.05 μM at 72 hrs for HSi and AHSi, respectively). The accelerated degradation of
H2O2 resulted from a combination of H2O2-Si-OH complexation on the surface and mild
catalytic effect of silica on H2O2 degradation

47

44, 101

. As a result, the increase in surface

area of the silica particle through increased porosity combined with the change in surface
chemistry led to a faster reduction in H2O2 concentration. However, these SiNP were not

Relative Concentration (%)

as effective as that of catalase, which completely decomposed H2O2 within 1 hr.
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Figure 11. Relative H2O2 concentration after incubation with Si particles or 1000 units of
catalase at pH 7.4 and 37oC. The starting H2O2 concentration was 100 µM.

3.4.3

Preparation and Characterization of Composite Adhesives

Catechol moieties were oxidized by NaIO4, resulting in the crosslinking and
polymerization of catechol. PEG-DA is end-modified with catechol and oxidative
crosslinking of catechol resulted in the curing of PEG-DA. The gelation time for PEGDA averaged around 36 s (Figure 12), when the precursor solution mixture stopped
flowing in a tilted vial. Si particles were incorporated into PEG-DA to form composite
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adhesives. Incorporating NSi reduced the gelation time slightly (31±0.82 s for PEG-NSi).
The PEG network likely formed physical entanglement with SiNP and catechol moiety
can form hydrogen bonds with Si-OH. These interactions contributed to the reduction in
gelation time as a result of forming new crosslinking points within the adhesive network.
Incorporating porous Si particles further reduced the gelation time (22±0.82 s and
21±0.82 s for PEG-HSi and PEG-AHSi, respectively). Increased particle surface area
likely increased the number of interactions between catechol and the particle surface,
effectively increased the rate of gelation.
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Figure 12. Gelation time of PEG-DA and its composite containing different silica
particles. *p<0.05 when compared to PEG-DA. **p<0.05 when compared to PEG-DA
and PEG-NSi.
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ATR-FTIR spectra of the Si particles revealed Si–O-Si peaks at 1065 cm-1 (Si–O
stretching) and 800 cm-1 (Si–O bending) as well as Si–OH bending peak at 950 cm-1
(Figure 13). The Si–OH peak intensity was noticeably increased for AHSi, which is in
agreement with the EDS result. The spectrum of PEG-DA exhibited characteristic peaks
corresponding to PEG (–C–O–C– at 1000–1150 cm−1, –CH2– at 2880 cm−1), carbonyl
group in ester bond (1729 cm−1) and aromatic ring in catechol (1400–1500 cm−1)

64

.

Incorporating the Si particles resulted in shifts over the peaks associated with Si–O–Si
(1030 cm-1 and 790 cm-1) and Si–OH (960 cm-1), confirming the presence of Si
particles in the composite adhesives. The shifts may be attributed to the overlapped signal
from PEG ether peaks (–C–O–C– at 1000–1150 cm-1)

107

.

Additionally, the peaks

associated with silica particle demonstrated reductions in intensity which indicated
hydrogen bond formed between the Si–OH and catechol or the oxygen atom of –C–O–C–
of PEG backbone.
Oscillatory rheometry was utilized to assess the effect of Si particles on the viscoelastic
properties of the adhesives (Figure 14). For all adhesive formulations, the storage
modulus (G’) values exceeded those of the loss modulus (G”), indicating that these
adhesive were chemically crosslinked

108

.

G’ values for PEG-DA at the linear

viscoelastic range were measured to be approximately 4.9 kPa, and adding 10 wt% NSi
particles significantly increased G’ (5.5 kPa for PEG-Si; p < 0.05 when compared PEGDA). This increase in the stiffness of the adhesive network is potentially due to increased
interactions between the Si particles and PEG-DA network

50

64, 86

.

Additionally,

incorporation porous Si particles further increased G’ values (5.9 and 6.2 kPa for PEGHSi and PEG-AHSi, respectively; p < 0.05 when compared PEG-DA and PEG-NSi).
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Figure 13. FTIR spectra of the Si particles (A) and PEG-DA containing the Si particles
(B). Dash lines indicate (from left to right for A and B) Si-O-Si (1065 and 1030 cm-1), SiOH (950 and 960 cm-1), and Si-O-Si (800 and 790 cm-1) peaks.
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Additionally, the decrease in the particle size and increase in the effective surface area
also contributed to the increased stiffness of PEG-DA composites

55

. This suggests that

increased particle surface area likely increased the number of interactions between
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Figure 14. Storage (A) and loss (B) modulus of PEG-DA and its composite containing
different silica particles.
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catechol and the particle surface, effectively increased mechanical property of the
composite adhesive. G” values for SiNP-containing composite adhesive were
significantly higher when compared to that of PEG-DA. This result indicates that
incorporating SiNP increased viscous dissipation properties likely through the formation
of physical interactions within the adhesive network 64, 86.
Bovine pericardium was used as the test substrate in lap shear adhesion test (Figures 15).
The adhesive strength for PEG-DA was measured to be 3.84±0.60 kPa. While it is
difficult to compare reported values from other PEG-catechol adhesives due to
differences in the method and substrate use, the values reported here are well within the
range of 103-104 Pa which is similar to the storage modulus reported elsewhere for PEGcatechol adhesives

64, 86

. This value increased with the addition of 10 wt% SiNP

(4.97±1.00, 6.87±1.35, and 7.35±1.01 kPa for NSi, HSi, and AHSi, respectively). The
addition of nanoparticles has been previously found to increase the adhesion strength in
catechol-based adhesives

64, 86

. Measured lap shear adhesion strength for PEG-AHSi was

the highest. The increased surface area in these particles likely increased the availability
of Si that can interact with catechol found in PEG-DA for forming hydrogen bonding.
This resulted in an increased bulk mechanical property and subsequently the adhesive
property. Similarly, elevated bulk mechanical property for PEG-HSi and PEG-AHSi
(Figure 14) also contributed to enhanced measured lap shear strength.
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Figure 15. Lap shear adhesion strength of PEG-DA and its composite containing
different silica particles using bovine pericardium as the test substrate. *p<0.05 when
compared to PEG-DA. **p < 0.05 when compared to PEG-DA and PEG-NSi
In vitro degradation of the adhesive was studied by tracking the change in the dry mass of
the fully crosslinked samples (Figure 16). PEG-DA degraded completely by week 8,
which is in agreement with PEG-catechol adhesive with ester linkages

64

. Incorporating

Si particles delayed the degradation of the composite adhesives. For PEG-AHSi,
approximately 40% of its original dry mass remained even after 8 weeks of degradation,
and the degradation rate was found to be approximately 8% per week. The delayed
degradation is likely a result of an increase in mechanical integrity as well as localized
pH reduction surrounding the silica particle

64, 86

. As amorphous silica particle degrades,

soluble silica species in the form of orthosilicic acid is released
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109

, which contributed to

the delayed degradation of SiNP-containing adhesive. PEG-DA degrades trough the
hydrolysis of the ester linkage between the glutaric acid and PEG

110

, and the hydrolysis

rate of ester bond is reduced in a mildly acidic pH 111.
ICP-OES was used to analyze the concentration of soluble Si released from Si particles
(Figure 17). Soluble Si can be derived from hydroxylated silicon surface in the form of
orthosilicic acid. PEG-NSi and PEG-HSi released less than 10 mg/L of Si over 24 hours,
whereas PEG-AHSi released nearly 3 folds higher Si over the same period of time. This
increased level of soluble Si suggests that acid treatment altered the surface chemistry of
Si particle to form the more hydrophilic Si-OH functional group. We speculated that the
nature of our particle synthesis resulted in noncrystalline particles which can react
promptly to formed surface groups of Si-OH when being exposed to oxidizing species or,
in some cases, deionized water 112. Additionally, the degradation rate of the silica particle
was reported to be highly dependent on surface functional groups including SiOH, their
protonated form (SiOH2+), and their deprotonated form (SiO-)

113

.

As a result, the

increases in degradation products, soluble silica or silicic acid, were expected as the
SiOH surface functional groups were increased after the acid treatment as demonstrated
by the EDS results.
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Figure 16. Normalized residual weight of PEG-DA and its composite containing
different silica particles. The samples were incubated in PBS (pH 7.4) at 37 °C. *p<0.05
when compared to all other groups
PEG-DA continuously generated H2O2 and reaching a maximum concentration of nearly
60 μM 6 hours after mixing the precursor solutions (Figure 18). Although PEG-DA
cured around 36 s (Figure 12), catechol can continue to polymerize to form oligomers
consisted of 6-7 catechol residues and generate H2O2 during catechol oxidative
crosslinking 40, 85. The oxidation of catechol produced superoxide which can participate to
further oxidize other catechol groups. The generated superoxide can further oxidize
catechol or interact with protons (H+) in the surrounding media to form H2O2. After
catechol ceased to undergo oxidative crosslinking, PEG-DA ceased to generate H2O2, and
the amount of H2O2 released from the adhesive decreased 40. Adding SiNP had minimal
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Figure 17. Soluble Si content of PEG-DA and its composite containing different Si
particles after 24 hour incubation in complete medium at pH 7.4 and 37oC. * p<0.05
when compared to all other groups
effect on the measured H2O2 concentration. However, adding the porous HSi and acidtreated AHSi drastically reduced the amount of the released H2O2 (44.27±1.50 μM and
34.30±1.83 μM for PEG-HSi and PEG-AHSi, respectively, at 6-hour time point). This
result indicated that incorporating Si particles with enhanced surface area and surface
modification can effectively reduce the amount of H2O2 generated during catechol
crosslinking.
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Figure 18. H2O2 concentration of PEG-DA and its composite containing different Si
particles. * p<0.05 when compared to all other groups. ** p<0.05 when compared to
PEG-DA and PEG-NSi

3.4.4

Effect of Incorporating Si Particle in PEG-DA on Cellular Response

The effect of incorporating Si particles into PEG-DA on the cell viability and
proliferation of primary fibroblast, keratinocyte, and tenocyte was investigated. For
fibroblast and tenocyte, PEG-DA reduced the relative cell viability to around 85% when
compared to the media control (Figure 19), and the incorporation of AHSi particle
significantly improves cell viability (> 95%). This is presumably due to the reduced
concentration of H2O2 released from PEG-AHSi. Interestingly, there was no difference in
the cell viability for keratinocyte when exposed to the three different adhesive
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formulations. Keratinocytes are more resistant to oxidative stress and can actively
degrade ROS 114. Keratinocyte viability was high even when it was exposed to PEG-DA,
which generated the highest concentration of H2O2 among the adhesive formulation
tested. An MTT assay was used to determine cell viability and normalized by cells that
were exposed to the cell culture medium. The result demonstrated that keratinocytes,
which were exposed to the adhesive extracts, had higher relative MTT signal when
compared to control. This increase in relative MTT signal was not observed in RDF and
HT. Specifically, keratinocytes exposed to the 3 adhesive formulations exhibited 30%
higher MTT absorption than the control cells, indicating that exposure to H2O2 likely
increases keratinocyte proliferation 114.
Ki-67 expression was utilized to determine the number of proliferating cells after
exposure to the adhesive formulation (Figure 20). For all cell types tested, cells exposed
to PEG-DA exhibited the lowest fraction of proliferating cells, which increased with the
incorporation of porous Si particles. Cells exposed to PEG-AHSi exhibited the highestlevel cell proliferation, a 3-4-fold increase when compared to cells exposed to PEG-DA.
Among the particles fabricated, AHSi releases the highest amount of soluble Si (Figure
10), which contributed to the observed increase in cell proliferation

76, 115

. The cellular

proliferation effect was not localized (Figure S6), potentially due to the rapid diffusion of
soluble Si in the culture

116

. Additionally, AHSi also significantly reduced the

concentration of H2O2 generated by catechol, which effectively promoted cell survival.
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Taken together, SiNP with increased porosity and modified surface chemistry was
utilized to control H2O2 generated during the curing process of catechol-based adhesive.
SiNP functioned as a filler in the composite adhesive and effectively increased its
crosslinking density and materials property. Most interestingly, these particles and their
composites were nearly chemically identical. However, the cellular response to these
materials was drastically different. Specifically, tenocytes are typically exposed to an
environment with low oxidative stress due to ischemic localized tissue compression in
tendons as well as the lack of vascularization in the native tissue

117, 118

. Exposure to

reduced concentrations of H2O2 increased the cell viability and proliferation of tenocyte.
On the other hand, keratinocytes can actively degrade ROS, and H2O2 has been
previously demonstrated to promote keratinocyte proliferation and migration

114

.

Keratinocyte demonstrated cell viability that was independent of the concentration of the
released H2O2. Our study points to the need to control H2O2 concentration depending on
the desired application. Depending on the biological system, the response to the released
H2O2 will likely be significantly different.
When compared to catalytic metal oxide and ions, SiNP provides a biocompatible
alternative to decompose H2O2. Although SiNP demonstrated reduced capability in
degrading H2O2 when compared to catalase, SiNP reported here provided added benefits
besides catalyzing the degradation of H2O2. Degradation product of SiNP mainly consists
of silicic acid, which are present in various tissues (e.g., bone and tendon) or organs (e.g.,
liver and kidney)

119, 120

. Silicic acid can also promote collagen synthesis and osteoblast

differentiation in vitro 121, 122. Soluble Si has also demonstrated the ability to promote cell
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Figure 19. MTT signal relative to culture medium control for primary rat dermal
fibroblast (A), human epidermal keratinocytes (B), and human tenocyte (C) after
incubated with PEG-DA and its composite containing different Si particles for 24 hours
in complete medium at pH 7.4 and 37oC. *p<0.05 when compared to PEG-DA. **
p<0.05 when compared to all other groups, respectively.
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primary rat dermal fibroblast (A), human epidermal keratinocyte (B), and human
tenocyte (C) exposed to adhesive for 24 hours in complete medium at pH 7.4 and 37oC. *
p<0.05 when compared to all other groups
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proliferation and migration, and accelerate dermal wound closure

76, 115

. PEG-AHSi

released the highest amount of soluble Si, which contributed to the highest Ki-67
expression in all three cell types that we tested. The incorporation of surface-treated SiNP
is potentially a facile and economical method to control H2O2 concentration while
improving the biocompatibility and adhesive performance of a PEG-based adhesive.
Additionally, by better controlling the concentration of H2O2 generated during the
crosslinking process of catechol-based adhesive, it can potentially enable these adhesives
for cell-engineering or cell delivery applications involving cells that are sensitive to
elevated oxidative stress.

3.5 Conclusions
In conclusion, increased porosity and acid treatment of SiNP greatly enhanced its ability
to decompose H2O2. When these SiNP were incorporated into PEG-DA, the amount of
released H2O2 was also significantly reduced. Additionally, incorporating these particles
increased lap shear adhesion strength, storage modulus, and altered the adhesive
degradation behavior. Furthermore, these SiNP increased the cell viability of primary
dermal fibroblasts and tenocytes, and the proliferation rate of these cells and
keratinocytes. Ultimately, incorporation of porous and acid-treated SiNP can be a useful
approach to simultaneously modulate the concentration of H2O2 while increasing the
adhesive performance of catechol-based adhesives.
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4 Systemic Study of Silica Particle-Catechol Composite
Adhesive on Dermal Wound Repair in Mice3
4.1 Abstract
The robust optimum design of the experiment was utilized to pinpoint catechol-based
polyethylene glycol (PEG) adhesive and their composite for the dermal wound healing
specific application. Experimental results confirmed that the incorporation of an acidtreated silica particle (AHSi) could reduce hydrogen peroxide byproduct of the catecholbased adhesive in a predictable range. The full-thickness dermal wound repair model in
mice was performed to study the effect of polymer architecture and incorporation of
AHSi. 6-arm PEG adhesive (PEG-D6) with the H2O2 producing nearly 100 µM was
shown to shorten the time required for wound closure by half. The addition of AHSi was
found to improve the tissue remodeling while maintaining the effective wound closure
speed observed in the PEG-D6. Ultimate, tissue-specific adhesive architecture and
composite formulation can be design to achieve the desired outcome, combing
accelerated wound healing with better wound remodeling.

4.2 Introduction
Wound healing is one of the most commonly studied topics in biomedicine. A number of
approaches have been proposed over the decades of biomedical material development to
treat tissue-specific wound healing. These approaches may include scaffolding, drug and
65

protein delivery, tissue engineering and transplantation, and bioactive dressing. Wound
dressing required means to adhere to skin or target tissue to provide structural support or
to cover the wound entirely. However, there are challenges when dealing with an open
wound or topical wound, which involves fluid management, wound irrigation,
antimicrobial, and sufficient material strength. Particularly, the most wound dressing will
not perform well in a wet environment 123-125.
Catecholic amino acid, 3,4–dihydroxyphenylalanine (DOPA), are naturally contained
within mussels adhesive proteins, which enables them to bind underwater surfaces 123, 126.
While oxidized, DOPA is capable of forming interfacial covalent bonds with organic
surfaces (e.g., tissues), making an interesting candidate for wound dressing under wet
environment

127, 128

. Catechol can be functionalized into synthetic polymers (i.e.,

polyethylene glycol) to produce strong, wet adhesive properties for various applications
129-131

.

Catechol adhesive must undergo oxidation in order to crosslink and adhere to surfaces 132135

. However, while doing so, the adhesive was found to release chemical byproduct in

the form of superoxide and hydrogen peroxide (H2O2) 36, 40, 136. The amount of superoxide
and H2O2 was measured to be between 10-104 µM range, depending on their architecture
36

. Recently, we have demonstrated that the incorporation of an acid-treated silica particle

(AHSi) can reduce H2O2 concentration from a polyethylene glycol-based catechol
adhesive. The composite adhesive demonstrates improved stiffness, adhesion strength,
and improved cellular response in vitro. The biological response was investigated with
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fibroblast, keratinocyte, and tenocyte 136. These cell types are known to react to H2O2 and
oxidative stress differently. Keratinocyte is known to demonstrate high resilience toward
H2O2 and oxidative stress following by moderately H2O2-tolerate dermal fibroblast and
non-H2O2 tolerant tenocyte 35, 40, 118. Hence, the ability to modulate H2O2 concentration is
required for the optimum biological response when targeting such cells and tissues.
To tune the H2O2 concentration of the adhesive, we introduce a bioactive silica particle,
AHSi, into the adhesive network. The architecture of the adhesive network (i.e., different
branch structure, crosslinking density, etc.) is known to inherently affect the H2O2
concentration

40, 136

. We have demonstrated previously that the incorporation of AHSi

particle effectively reduces H2O2 concentration by 50% in an 8-arm polyethylene glycol
(PEG) based adhesive, potentially due to the surface interaction between silanol group on
the particle surface with H2O2 under wet condition 136. We hypothesized that variation of
PEG adhesive architecture would allow for better control over H2O2 generation while
maintaining the adhesive properties of the composite. The resulting composite adhesive
should also demonstrate a better biological response as a result.
To this end, we systematically study the varying catechol adhesive composite containing
AHSi. Gelation time, H2O2 concentration, and adhesive strength of the adhesive and their
composites have been investigated. Full-thickness dermal wound repair mice model study
was carried out to determine the effect of different adhesive architecture as well as the
effect of AHSi addition on dermal wound healing.
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4.3 Materials and methods

4.3.1

Materials

4-arm, 6-arm, and 8-arm Polyethylene glycol (10kDa, 15 kDa, and 20 kDa, respectively,
Jenkem, TX, USA), Sodium periodate (NaIO4, >99.8%) were obtained from Acros
Organics (Fair Lawn, NJ). Phosphate buffer saline (PBS), tetraethyl orthosilicate (TEOS,
99.8%), ethanol (200 proof), sodium hydroxide, and acetic acid (Glacier) were purchased
from Fisher Scientific Co. (Pittsburgh, PA). Histology mounting medium Polyfreeze,
Trichrome Stain (Masson) Kit, Bouin's solution, and Weigert's iron hematoxylin solution
were purchased from Sigma-Aldrich (St. Louis, MO). goat anti-rabbit IgG H&L (Alexa
Fluor 488) (ab150077), anti-CD68 antibody (ab125212), and goat anti-rabbit IgG H&L
(Alexa Fluor 647) were purchased from Abcam (Cambridge, MA). 4,6-Diamidino-2phenylindole (DAPI) was obtained from Invitrogen (Grand Island, NY).

4.3.2

Synthesis, Preparation, and Characterization of PEG-DA Adhesives and
their composites

The synthesis of PEG-DA adhesive was synthesized with 4, 6, and 8-armed PEG
(MW=10, 15, and 20 kDa, respectively, JenKem USA, TX) according to a previously
published protocol

64

. After purification, the adhesive was analyzed via NMR (Varion

400 MHz) to determine the catechol coupling efficiency via H1-NMR with D2O.
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The preparation of PEG-DA adhesive was done according to a previously published
protocol

136

. Briefly, PEG-DA (100, 225, or 300 mg) was dissolved in 1 ml of PBS

solution (1x, 2x, or 4x) to create a PEG-DA precursor solution. The addition of acidtreated silica particle (AHSi) (0, 5, or 10%wt) was done in the precursor solution to
create a composite precursor solution. The particle was synthesized previously with the
published protocol136. 11.6 mg of NaIO4 was dissolved in 1 ml of deionized water to
create NaIO4 solution. The precursor solution and NaIO4 solution were mixed at a 1:1 v/v
ratio to create PEG-DA adhesive and composites. The gelation time of the adhesive and
the composite was determined with vial tilting technique as the adhesive gel rapidly. The
adhesive was considered gelled when the solution ceased to flow in a scintillated vial.
Lap shear adhesion test was performed using bovine pericardium while following a
previously published protocol according to ASTM standard F2255-05

64

. Strips of

pericardium tissues (2.5 cm x 2.5 cm) were kept moist in PBS. 100 μl of PEG-DA
precursor solution and NaIO4 solution with and without Si particles were mixed in a
scintillated glass vial before being transferred on to the surface of the tissue. Another
piece of pericardium tissue was applied over the adhesive to create an adhesive joint
(overlapping area of 2.5 cm2), which was compressed with a 100-g weight for 15 min.
The adhesive joint was submerged in PBS (pH = 7.4) at 37 °C overnight prior to testing.
A digital caliper was used to measure the dimensions of the overlapped area of each
adhesive joint before testing. The fixation of the tissue pieces on to the test stage was
done with serrated metal grips to ensure sufficient traction. An Electroforce® machine
(Bose Electroforce Group, MN) was used to pull apart the adhesive joint to failure at a
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rate of 0.1 mm s−1. The adhesive strength was determined by the maximum load divided
by the initial overlapped area of the adhesive joint.

4.3.3

Systemic Study of H2O2 Release in PEG Adhesive Composites

The robust design was utilized to predict the H2O2 concentration. The prediction was
made utilizing the measured data from multiple experiments. Each factor that affects the
material behavior was listed and ranked according to how large the effect of their change
can be. PEG architecture, PEG precursor concentration, PBS concentration, and amount
of incorporated AHSi were identified as largely affect the properties of the adhesive. The
three properties that would significantly affect the material performance were determined
(including gelation time, H2O2 concentration, and adhesive strength) as they are the most
commonly reported value

136

. Each factor was calculated through the mean value

retrieved from real experiments. The mean observation value of the experiment was used
to calculate the signal to noise ratio. Mean signal to noise ratio was then used to assign
the weight to the factor effects. The equation used to find the signal to noise ratio for each
formulation is as follow:
S/N = -10×LOG(MSO)

(4)

Where S/N is signal to noise ratio and MSO is mean squared observation. MSO can be
calculated by
MSO = ((1÷X12)+(1÷X22)+… +(1÷Xn2))/n
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(5)

Where X is the experimental data of each repeat, subscript denotes the repeat counts, and
n is equal to the total number of repeats.
The factor effect can then be complied from compiling signal to noise ratio into a 3*4
matrix assigning the signal to noise prediction to each factor to each set of change 137, 138.
Nine sets of experiments were conducted to collect the data needed for the predictions
(Table 4).
Table 4. Formulation required to fulfill the robust design matrix requirement
Factors
Experiment

PEG

PEG conc.

PBS conc.
%wt AHSi

Architecture

(mg/ml)

(x0.01M)

1

4

150

1

0

2

4

225

2

5

3

4

300

4

10

4

6

150

2

10

5

6

225

4

0

6

6

300

1

5

7

8

150

4

5
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4.3.4

8

8

225

1

10

9

8

300

2

0

Systemic Study of PEG Composites in Dermal Wound Model in Mice

The adhesive formation was selected to minimize the number of mice required to obtain
meaningful data from the animal experiment. The first study criterion is the effect of the
particle incorporation, which is a continued investigation from the in vitro result
previously published form our group

136

. The formulations were chosen to demonstrate

the effect of the particle on the predicted reduction in H2O2 concentration and the
increase in soluble silica concentration released from the composite. The second study
criterion is the effect of the PEG-DA structure and their native H2O2 byproduct. The
formulations were chosen to demonstrate the effect of the architectural alteration as well
as the change in H2O2 concentration and release profile (Table 5). The number of mice
required for bilateral experiment with three extra mice as backup is equal to 17 (Table 6)
Table 5. Formulation to be tested with the full thickness dermal wound in mice
Formulation

Silica Composite

Group

Control

None

A

PEG-D6

None

B

PEG-D4

10%wt AHSi

C
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PEG-D6

10%wt AHSi

D

PEG-D8

10wt% AHSi

E

Table 6. Full list of treatments for all mice in the full thickness dermal wound repair
experiment
Mice#

L

R

Time (Day)

1

A

B

14

2

B

C

14

3

C

D

14

4

D

E

14

5

E

A

14

6

B

A

14

7

C

E

14

8

D

C

14

9

B

E

7
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4.3.5

10

A

E

7

11

A

D

7

12

E

D

7

13

C

A

7

14

D

B

7

15

E

C

7

16

B

D

7

17

C

B

7

Full Thickness Dermal Wound Repair model

Female wild type mice (age 9-10 weeks, weight 20 g) were used to study the fullthickness dermal wound model. All mice were subjected to a full-thickness wound model
protocol modified from previously published protocols (Figure 21)

139-141

. Mice were

anesthetized with isoflurane before the hair was removed with electric shear and hair
removal cream. One day after hair removal, the mice were anesthetized, and a 5 mm
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Figure 21. Illustration (A) and photograph (B-I) of the step-by-step process of fullthickness wound repair model in mice.
tissue punch was used to create the wound on the back of the mice bilaterally to ensure
identical wound size. Medical-grade silicon ring (outer diameter 10 mm, inner diameter 6
mm) was fixated to the wound as a splint to prevent skin movement and change in wound
size due to skin relaxation and shrinkage. The ring was first fixed with cyanoacrylate glue
75

then 5-0 nylon suture was used to fix the ring with the skin. Four suture spots were used
to ensure tight fixation as the fixing ring must survive until day 7 or 14. The wound was
left open or was treated with PEG-DA adhesive and their composites. Images of the
wound were taken for wound size analysis. The adhesive was allowed to gel for 2
minutes before the wounds are covered with a non-stick wound dressing mesh (Adaptic).
Sticky and breathable adhesive film (Hydrofilm) was used to attach the non-stick mesh
on to the skin surrounding the wound. A large adhesive film piece was then used to
completely seal off the wound from the surrounding element. The pain killer was given to
the mice at 20 µl/day for three days after the surgery to ensure animal comfort. Wound
dressing was inspected and replaced every day for the first four days after surgery.
Images were taken at the same time as the wound redressing. Depending on the time
group the mice were in, they were euthanized on day 7 or 14.

4.3.6

Immunological and Histological Analysis of Dermal Wound Model

After 7 or 14 days, the animals were euthanized via CO2 asphyxiation. The images of the
extracted tissue samples were taken for wound size analysis via an Olympus microscope.
The tissue samples were fixed in Polyfreeze and flash-frozen in a liquid nitrogen bath.
The tissue was kept in -80oC for up to 4 weeks before sectioning with a cryomicrotome.
The tissue slices were processed at the thickness of 10 µm mounted onto Histobond slide.
There were 3 tissue section on each slides, at least 10 mounted tissue slides were
produced for each tissue sample.
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The immunological analysis of the dermal wound was done via CD68-DAPI fluorescence
staining for macrophage population. The macrophage staining was done according to
previously published protocol with minor modification

64

. Samples were obtained from

the -80°C freezer and fixed in 100% ethanol for 2 minutes. Samples were then washed 3
times in PBS with Tween 20 (PBST) - 5 minutes each wash. Circles were then drawn
around each sample using a hydrophobic marker. Endogenous blocking was completed
using 10% Goat Serum diluted using 1% Bovine Serum Albumin (BSA) for 60 minutes.
Samples were washed again in PBST 3 times - 5 minutes per wash. Next, samples were
incubated in a 1/100 dilution Primary Anti-CD68 Ab (ab125212 – Rabbit Polyclonal) for
12-14 hours at 4°C in a humidified chamber. Samples were washed again in PBST 3
times - 5 minutes per wash and the lights remained off for the remainder of the stain. The
samples were then incubated in a 1/200 dilution of the Secondary Antibody (Goat AntiRabbit IgG H&L – AlexaFlour488) for 60 minutes at room temperature. Samples were
washed again in PBST 3 times - 5 minutes per wash before being incubated in a DAPI
antibody (1/1000 dilution) for 3 minutes and then the wash was repeated. Samples were
mounted using an aqueous mounting medium and were imaged with 2-3 hours of the
stain being completed. CD163 (M2-polarized macrophage stain) was not used. Image of
the sample was taken immediately after the staining.
The histological analysis of the dermal wound tissue was done via trichrome staining for
wound morphology, epidermis analysis, and collagen content analysis. The trichrome
staining was done according to previously published protocol
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. Samples were mounted

using a permanent mounting medium. Additionally, keratin 6 staining was utilized to
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analyze the wound maturity through the population of keratinocyte. The keratin 6
staining was done according to previously published protocol with minor modification
142

. Instead of counterstaining with toluidine blue to stain the nuclei, Gill’s 3 hematoxylin

solution (Sigma Aldrich) has been used in place of toluidine blue. Briefly, samples were
rinsed in tap water and then immersed into the hematoxylin solution for 1-5 minutes.
Samples were then rinsed in running tap water until thewater was colorless. The samples
were then dipped 10 times in an acid rinse solution (2mL glacial acetic acid + 98mL diH
2 O) followed by 10 dips in cool tap water. Then slides were dipped 5 times in a bluing
solution (0.3mL NH 4 OH +100mL tap water) followed by 20 dips in tap water. Samples
were then mounted using a permanent mounting medium and were stored overnight at
4°C before imaging.
Trichrome and keratin 6 stained tissue samples were imaged via EVOS microscope under
polarized light. The overlaid images were processed via the Adobe Photoshop program
auto stitching module. All image was measured and analyzed via ImageJ with wound
healing tool macro with modifications 143.

4.3.7

Statistical Analysis

Statistical analysis was performed using JMP Pro 13 application (SAS Institute, NC).
One-way analysis of variance (ANOVA) with Tukey-Kramer HSD analysis was
performed for comparing means. p< 0.05 was considered significant.
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4.4 Results and discussion

4.4.1

A systemic study of H2O2 release in PEG adhesive composites

The PEG-D4, PEG-D6, and PEG-D8 adhesive were synthesized (Figure 22). NMR
spectra of each PEG adhesive have been analyzed (Appendix A). The coupling efficiency
of each PEG adhesive was found to be over 90%. Ensuring their performance as
adhesives with catechol functionalization. The formulation tested can be seen in Table 7.
The difference between the predicted value and the experimental data are apparent on the
effect of incorporating silica particle into the adhesive (Figure 23A and C). Adding silica
particle was proven to reduce gelation time and increase adhesive strength

86, 136

.

However, the prediction model does not agree with this understanding. On the other
hand, prediction on H2O2 concentration is effective enough to be able to predict the
concentration of H2O2 at a 10-20% increase from the tested value (Figure 23B).
Interestingly, the addition of AHSi provided a reduction in H2O2 by 20.24±0.67 µM
regardless of PEG architecture, PEG concentration, and PBS concentration. The clearly
limited reduction indicated that the effect of the particle on H2O2 reduction is governed
by the available binding site on the particle 45, 136. As a result, the prediction model is not
perfectly predicted the H2O2 concentration and completely ineffective in predicting
gelation time. However, the prediction on the trend of H2O2 can be utilized to narrow
down the formulation to be tested via maximum H2O2 concentration. The predicted
formulation that fits the criteria for dermal wound repair can be seen in Table 8. All
prediction data can be seen in Appendix A.
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Figure 22. Chemical Structure of PEG-D4, PEG-D6, and PEG-D8. Single carbon (A),
dipentaerythritol (B), and hexaglycerol (C) were used as the center group.
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Table 7. Experimental result of the formulations required to fulfill the robust design
matrix requirement
Gelation

Time

Experiment

Adhesive Strength
H2O2 (µM)

(second)

(kPa)

1

273.33±8.98

92.35±2.01

-

2

45.83±3.44

89.30±1.72

3.17±0.18

3

167.50±4.79

68.31±2.14

3.62±0.29

4

515.00±13.84

52.36±1.91

-

5

39.17±1.68

78.17±2.08

3.10±0.20

6

52.83±2.27

72.22±2.15

5.31±0.16

7

358.33±7.45

26.85±2.59

-

8

85.50±4.23

32.33±1.49

4.26±0.29

9

37.50±4.79

61.35±3.01

7.07±0.63
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Table 8. Predicted formulation that fit the criteria for dermal wound repair
PEG

Concentration PBS

%wt

Gelation

H2O2

Adhesive

Architecture (mg/ml)

conc.

AHsi

Time

conc.

Strength

6

300

2

0

35.94

108.84

5.74

6

300

2

10

95.57

69.54

5.11

8

300

2

10

97.24

39.04

6.23

4

300

2

10

119.58

86.27

4.52
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Figure 23. Prediction vs. Experimental result of gelation time (A), maximum H2O2
concentration (B), and adhesion strength (C). *p<0.05 when compared to their pair
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4.4.2

Dermal Wound Model in mice

4.4.2.1 Wound closure
Wound size measurement on the mice was done in a time-dependent manner. There was
no difference in the wound size immediately after the surgery (Figure 24 and 25).
However, after 7 days, the size of all the adhesive treated wounds is significantly smaller
than the control wound. This is potentially due to the introduction of a physical coverage

Control

PEG-D6

PEG-D6-AHSi

PEG-D4AHSi

PEG-D8-AHSi

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

Figure 24. Representative image of the harvested tissue at day 0 (top), 7 (middle), and 14
(bottom) of control (A,F,K), PEG-D6 (B,G,L), PEG-D6-AHSi(C,H,M), PEG-D4-AHSi
(D,I,N), and PEG-D8-AHSi (E,J,O). Red and yellow dash line indicates the wound area.
Scale bars are 1 cm.
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over the wound as well as the release of H2O2 in the first few days can help recruit
immune cells as well as act as a chemotaxis source for keratinocyte recruitment. PEGD8-AHSi was found to have the smallest wound size among all the adhesive treated
wounds. This may be due to the fact that the composite releases the least amount of H2O2,
which might contribute to the shrinkage of the wound. Additionally, the wound treated
with adhesives are seemingly completely closed.
On day 14, control wounds have the scar tissue three times larger than all of the adhesive
treated wounds. All catechol-AHSi composite treated wounds were found to have
reduced wound size when compared to control suggesting that incorporation of soluble
silica can induced faster wound closure when compare to the open wound. Interestingly,

*

*

*
*

*

Figure 25. The wound area of the control wound and wound treated with different
formulations of the adhesive. *p<0.05 when compared to their pair

85

only PEG-D6 AHSi and PEG-D4 AHSi showed significant differences when compare to
PEG-D6. We speculated that the H2O2 concentration level (50-80µM) and, presumably,
increases in matrix stiffness contributed to such change when combined with the release
of soluble silica 40, 64.

4.4.3

Immunological Analysis of Dermal Wound Model

To evaluate the effect of the particles on the biological response of the composite
adhesives, catechol-based adhesive and their 10%wt AHSi composite with either 4,6, or 8
arms architecture were introduced in on to the dermal wound repair model for 7 and 14
days. 1*1 mm box was used to randomly selected the analysis area where the CD68
positive cells, labeled in both green and blue, was count against the total population of
cells, labeled in blue. A total of 3 counts was done for each image within the wound
proximity then the counts were calculated for the approximation of CD68 population
ratio. The ratio of CD68 to total cell number was found to be the highest in the first 7
days then reduced to the lowest level in the control wounds (Figure 26 and 28).
Interesting, both PEG-D6 and PEG-D6-AHSi demonstrated a significant reduction of
CD68 population when compare to control on day 7 indicating lowered immunological
response. Inversely, at day 14, the ratio of CD68 population of all adhesive and
composite treated samples were found to be significantly higher than the control
indicating increased immunological response (Figure 27 and 28). This increase in CD68
population on day 14 suggested a prolonged immunological response. However, the
macrophages involving in wound healing were thought to be roughly divided into two
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types, M1 – inflammatory response and M2 – matrix remodeling. M2 macrophages are
responsible for suppressing inflammatory responses, matrix remodeling, and tissue
regeneration

64

.The CD68 staining indicates only the population of macrophage without

distinguishing the types of the cells. We speculated, with support from trichrome and
keratin-6 results (Figure 31 and 34, respectively), that the wound remodeling
macrophage is the dominant macrophage types in these wounds. The ratio of CD68
population was not significantly different between PEG-D6 and PEG-D6-AHSi
indicating that the inflammatory response of the two treatment groups are similar.
However, the differences between PEG-D4 and PEG-D8 to PEG-D6 and PEG-D6-AHSi
were observed. These results indicating that the wound react to the release of soluble
silica and narrow shifts in H2O2 as PEG-D4 has higher H2O2 than PEG-D6 while PEG-D8
has lower H2O2 concentration than PEG-D6. We theorized that the combination of
soluble silica (≥10 µM) and H2O2 level at around 60 µM might be the ideal concentration
to accelerate wound healing without causing significant increase in immunological
responses similar to previous findings 64, 115.
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Figure 26. Representative CD68-DAPI immunological image of the harvested tissue on
day 7 after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi
(D), and PEG-D8-AHSi (E). Yellow dash line box giving the example for the area used
to calculate CD68 positive cells. White dash line indicates the wound proximities. Green
= CD68 positive cells and blue = cell nucleus. Scale bars are 1 mm.
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Figure 27. Representative CD68-DAPI immunological image of the harvested tissue on
day 14 after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi
(D), and PEG-D8-AHSi (E). Yellow dash line box giving the example for the area used
to calculate CD68 positive cells. White dash line indicates the wound proximities. Green
= CD68 positive cells and blue = cell nucleus. Scale bars are 1 mm.
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Figure 28. The ratio of CD68 positive cells of the wound treated with different
formulation of the adhesive. *p<0.05 when compared to their pair

4.4.4

Histological Analysis of Dermal Wound Model

Healthy skin tissue is comprised of the epidermis, dermis, panniculus muscle, and
subcutaneous adipose tissue (Figure 29). When skin experience trauma, clotting cascade
will be initiated to stop the bleeding, then an inflammatory response will start by
recruiting neutrophil, macrophage, and fibroblast. The granulation tissue (gr), which is a
vascularized, not-well-defined tissue, and connective tissue will start from. The amount
of granulation tissue and connective tissue is governed by the healing process of the
wound. With higher inflammatory response and heal poorly, higher connective tissue and
collagen synthesis are to be expected. At a later stage of a healing wound, tissue

90

remodeling occurred, and the tissue structure will start to resemble a healthy skin
structure. On the other hand, poorly healed scars will end up with an excess amount of
collagen as well as poor tissue remodeling, causing the newly formed skin to look
distinctly different than that of healthy skin.
Histological staining images were collected and analyzed with 2 tissue slides from 3
repeat of each sample group (n=6 for each group). Masson’s trichrome staining is
generally utilized to study the skin tissue for their morphology and structural content of

A

B

C

Figure 29. Histological analysis of skin structure and thickness. Scheme of skin structure
(A), histological skin sections stained with Masson trichrome and collected from young
(8-12 week-old) and old (16-20 week-old) mice fed with normal diet for a period of 8
weeks (B), quantification of the skin layers thickness: the epidermis (C) Epi - epidermis,
dWAT - dermal white adipose tissue, F-rd fibroblast rich dermis; scale bar 200 μm.
Adapted from reference 144 under the terms of the Creative Commons Attribution License
(CC BY 3.0)
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the sample. Trichrome staining on skin tissue stains collagen in blue, muscles, and other
connective tissues in red, and cell nucleus in dark brown (Figure 29).
The wound proximities were found to be in irregular shapes, which are the result of
dermal contractions

145

. The results from tissue sample harvested on day 7 after surgery

indicate a faster wound healing in the adhesive treated samples with thicker epidermis
formation when compared to control (Figure 30 and 32A). This increased epidermis
thickening or dermal hyperplasia is thought to be the effect of H2O2 treatment, as
reported by others in the field 146, 147. The thickest epidermis layer was observed in PEGD4-AHSi, which has the highest H2O2 concentration among the composite samples
following by PEG-D6-AHSi and PEG-D8-AHSi, which has the lowest H2O2
concentration (Figure 23B). PEG-D6 treated sample also demonstrated an increase in
epidermal thickness, but the increase is not significantly different than those observed in
PEG-D6 AHSi and PEG-D4-AHSi. The result suggested that the increase in epidermal
thickness is not only affected by hydrogen peroxide concentration but also the release of
soluble silica.
The collagen content determined through the measurement of collagen layer thickness.
The thickness of the collagen layer in the control sample tissue is significantly thicker
than those of the adhesive treated samples (Figure 30 and 32B). The granulation tissue
formation was found to be the most prominent in PEG-D4-AHSi, which has the highest
amount of H2O2 (>80 µM) followed by PEG-D6-AHSi (between 40 and 80 µM), and
PEG-D8-AHSi (<40 µM). Interestingly, PEG-D6 (approximately 100 µM of H2O2)
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treated wound demonstrate dermal layer structure, which resembles those of healthy
tissue the most. This may be due to the fact that a high concentration of H2O2 (as low as
1000 µM for one-time dose) can leads to epidermolysis and rapid new epidermal
formation with epidermal hyperplasia as evident in the epidermis analysis

93, 147

.

However, this result is not consistent across all the mice, which strongly suggested by the
large standard deviation. This is to be expected as the lack of control over the release of
H2O2 release as well as weaker material integrity, resulting in a large variety of biological
responses.
Trichrome staining results of tissue samples harvested on day 14 after surgery indicate
healthy wound remodeling on all adhesive treated samples (Figure 31). Smaller wound
proximity, as well as increased granulation tissue and reduction in collagen layer
thickness, have been observed in all adhesive treated formulation. PEG-D6 and PEG-D6AHSi demonstrated tissue remodeling, which is resembling healthy tissue. A similar
tissue remodeling trend was also observed in PEG-D4-AHSi, and PEG-D8-AHSi treated
samples. However, the collagen thickness is higher in these groups when compared to the
PEG-D6 and its composite. This might be attributed to the fact that the healing process of
PEG-D6 involved early thermolysis and new epidermal formation since the hydrogen
peroxide concentration of the adhesive is closer to 100 µM at their maximum
concentration. For PEG-D6-AHSi, it is possible that the amount of sustained release of
H2O2 resulted in a similar biological response at day 14 as the lagged healing process was
observed in day 7 sample groups. PEG-D6—AHSi demonstrated the thinnest collagen
layer (Figure 32) which might suggest that the wound remodel successfully at day 14.
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Figure 30. Representative trichrome histological image of the harvested tissue on day 7
after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D),
and PEG-D8-AHSi (E). Black (A-B) and Yellow (C-E) dash line indicate the area used to
calculate collagen content. White dash line indicates the wound proximities. es = eschar,
gr = granulation tissue, and ep = epidermis. Scale bars are 1 mm.
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Figure 31. Representative trichrome histological image of the harvested tissue on day 14
after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D),
and PEG-D8-AHSi (E). Black (A and C) and Yellow (B, D, and E) dash line indicate the
area used to calculate collagen content. White dash line indicates the wound proximities.
es = eschar, gr = granulation tissue, and ep = epidermis. Scale bars are 1 mm.
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Figure 32. The epidermis thickness (A) and collagen layer thickness (B) of the wound
treated with different formulation of the adhesive. *p<0.05 when compared to their pair
Interestingly, all-composite adhesive treated samples demonstrated a significantly thinner
epidermal when compare to PEG-D6 (approximately 25 µm vs. 140 µm), suggesting the
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lack of epidermal hyperplasia. In fact, the thickness of the epidermal in these treatment
groups matched with the thickness of epidermal in the healthy tissue in the wild-type and
age-matched mice (Figure 29C.)144. Interestingly, the keratinocyte population observed
in both PEG-D6-AHSi and PEG-D8-AHSi (H2O2 concentration <80 µM) are significantly
higher than those observed in both PEG-D6 and PEG-D8-AHSi (H2O2 >80 µM). The
result suggested that AHSi addition combining with appropriate adhesive architecture or
H2O2 concentration, i.e., PEG-D6-AHSi, can lead to wound remodeling, which resembles
healthy tissue without epidermal hyperplasia.
Keratin-6 suggested that adhesive treatment increase keratinocyte recruitment. In
addition, adding particle in the adhesive further increases keratinocyte recruitment on day
7 after surgery (Figure 33 and 35). Keratinocyte content is a sign of skin maturation as
keratinocyte maturation completes the cornification of the skin, providing the outermost
layer of protection to the dermal tissue below

148

. The increase in keratin 6 positive cell

population in the epidermis and surrounding tissue (approximately 82% with higher than
90% in the epidermis) in adhesive treated samples suggested that the skin can undergo
maturation earlier than the control sample for at least a week. The population of
keratinocyte was found to be concentrated in the epidermis and the surrounding tissue,
which conforms with normal skin tissue structure149,

150

. H2O2 was found to increase

keratinocyte proliferation as a response to oxidative stress38, 151. Moreover, soluble silica
is also reported to increase keratinocyte proliferation as well as induce fibroblast and
keratinocyte migration

76, 136

. Additionally, incorporation of silica particle increases the

stiffness of the adhesive, which contribute to fibroblast and keratinocyte proliferation
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Figure 33. Representative keratin-6 histological staining images of the harvested tissue at
day 7 of control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D), and PEG-D8AHSi (E). Red dash line indicates the area used to calculate keratinocyte content. White
dash line indicates the wound proximities. Scale bars are 1 cm.
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Figure 34. Representative keratin-6 histological staining images of the harvested tissue at
day 14 of control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D), and PEGD8-AHSi (E). Red and yellow dash line indicates the area used to calculate keratinocyte
content. White dash line indicates the wound proximities. Scale bars are 1 cm.
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Figure 35. The ratio of keratin-6 positive cells of the wound treated with different
formulation of the adhesive. *p<0.05 when compared to control in the same time group
when direct cell-material contact was established

136,

152

. The control sample

demonstrated the least amount of keratin-6 positive cells suggesting the lagged
maturation progress.
Keratin 6 stainings on tissue samples harvested on day 14 after surgery showed an
increase in keratinocyte population in control samples, while a general reduction in the
population was observed in all samples with adhesive treatment. The keratinocyte
population in all adhesive treatments were not significantly different and was found to be
around 40% of the total cell population (approximately 40% with 90% in the epidermis).
This reinforces the assumption that the introduction of adhesive treatment was
contributing to the early maturation of keratinocyte and keratinocyte recruitment.
The population of keratinocyte reduced 14 days after surgery samples (Figure 34 and
35). This is presumably due to the early maturation of the keratinocyte allowing the
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dermal tissue remodeling as keratinocyte are key cells that regulate dermal fibroblast
activity and dermal wound healing

149

. This observation correlated with the trichrome

staining result, which suggested the near-complete tissue remodeling in PEG-D6-AHSi
treated sample (Figure 31C.).
The combination of trichrome and keratin 6 (Figures 32 and 35) strongly suggested the
H2O2 concentration-dependent response of dermal wound healing

147,

153

. The

concentration of H2O2 that presumably accelerate wound healing was reported to be
varying from 10-103 µM. However, with the full thickness wound model result, we
narrow down the concentration that specific to the dermal wound to be between
approximately 40-100 µM. However, H2O2 alone does not contribute to fully remodeled
tissue at 14 days after the injury, as suggested by epidermal hyperplasia observed in the
PEG-DA adhesive treated samples (Figure 31 and 32A). The incorporation of AHSi,
which can release soluble silica in a biologically relevant concentration, also contributes
strongly to the epidermal formation and tissue remodeling

136, 148, 149

. The particle

participates in reducing the H2O2 concentration while altering the material stiffness,
which positively affects the wound healing process in vivo136. The wound was remodeled
to mostly resemble healthy tissue on day 14 after the injury, as demonstrated by
trichrome staining. The lack of epidermal hyperplasia suggested no excessive thermolysis
and inflammatory response took place during the healing process. AHSi or soluble silica
was demonstrated to play a critical role in inducing keratinocyte and fibroblast
proliferation and migration, which directly affect dermal wound healing in vitro

76, 136

.

For the observed in vivo results, the author proposes the simplified relationship between
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H2O2, material property, and AHSi (Scheme 4) to help better understand the interaction
observed in this manuscript. However, the full understanding of the AHSi or soluble
silica, and their biological effect is not fully understood and should be considered to be a
fruitful endeavor for future study.

Scheme 4. H2O2, material property, and AHSi on dermal wound healing
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4.5 Conclusions
10%wt silica nanoparticle-containing adhesive hydrogels were formulated to tune the
H2O2 concentration released from the PEG-DA adhesive with various architecture. The
robust design of the experiment was utilized to narrow down the candidate formulation
and expected H2O2 concentration for dermal tissue repair application. FOX assays
confirmed the amount of H2O2 can be estimated through robust design with a 10-20%
deviation. Incorporation of silica particle effectively reduces the H2O2 concentration
released from the adhesive regardless of their architecture. Lap shear tests confirmed the
adhesive improve their adhesive strength with the addition of silica particles. The
adhesive was successfully introduced in a full-thickness wound repair mice model. The
result suggested that the adding catechol adhesive helped accelerate wound closure but
fail to achieve a fully remodeled to healthy dermal tissue due to epidermal hyperplasia.
The addition of AHSi proves to be beneficial for the adhesive in maintaining the ability
to accelerate wound healing while reducing the epidermal hyperplasia. Ultimately, with a
combination of appropriate adhesive architecture, H2O2 concentration, and addition of
AHSi, an accelerated wound healing with better tissue remodeling was achieved. This
proof of concept study strongly suggests the design of adhesive that considered the
aforementioned factors to achieved tissue-specific response. However, a full
understanding of the target tissue and their healing process is required to utilize this
strategy effectively.
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5 Summary and Future Outlook
5.1 Summary
In Chapter 1, we established an understanding of ideal bioadhesive design and catechol
based adhesive. The byproduct of catechol-based adhesive and the effect of H2O2 on
biological response was discussed at length. We thus proposed the alternative approach to
control the release of H2O2 from catechol adhesive with a biologically active silica
particle incorporation.
Chapter 2 revolves around the detailed investigation of silica particle synthesis and the
exploratory investigation on altering surface chemistry on the silica particle. In the later
part of the chapter, we have describes the factor that directly affects silica particle
synthesis, especially with Stӧber synthesis approach. Several surface modification
techniques have also been investigated with the resulting silica particle. This was further
corroborated by various tests on the particle surface interaction with H2O2 in chapter 3
with various methods at physiological conditions.
Although the particle demonstrated promising characteristics and interaction with H2O2,
the application of such a particle is still unproven. In chapter 3, we investigate the effect
of the particles on H2O2 generation and the effect of incorporating the particle on various
types of cells and in the wound healing model in mice. We demonstrated that the particle
still remains effective even after incorporation into PEG-DA adhesives in reducing H2O2
concentration. The particle also positively affects the biological response of RDF, HT,
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and HEK, increasing cell proliferation and reduce toxicity in some formulation. The
results were indicating that targeted-application and targeted-tissue adhesive design from
such a concept can be achieved.
The ability of the silica particle and composite adhesives (reported in Chapters 2-3) to
modulate the different concentrations of H2O2 was thought to be largely limited by the
availability of surface binding sites as well as slow degradation of H2O2. To address this
concern, in Chapter 4, we study a wider range of adhesive formulations to find the extent
of H2O2 modulation that the particle can provide. We demonstrated that, with careful
selection of material and their control factors, a representative formulation from silica
particle-PEG-DA composite could achieve the desired biological response in vivo via a
full-thickness wound repair model in mice. The results strongly suggested that, with
appropriate selection and control of H2O2 release level, dermal wound healing time can
be reduced by at least 50% with a complete tissue remodeling.

5.2 Future Outlook
This dissertation describes the progress made toward controlling the H2O2 concentration
during the oxidation of catechol adhesive through oxidative mediated oxidation by the
introduction of surface activated silica particle for H2O2 sorption and complexation. The
assays for multiple formulations of PEG-DA adhesives and particle composites were also
included, which will facilitate the decision of formulation selection for future studies.
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In Chapters 2-3, the particle was synthesized as a fully amorphous particle to allows
better surface reactivity and ease of functionalization. Increasing the total surface area of
the particle proves to be one of the effective modifications to increase the particle
capability to react with H2O2. Alternatively, post-synthesis heat treatments or adjustments
during synthesis (i.e., increased temperature, change of silica precursor, etc.) can be made
to alter the degree of crystallinity. A stronger functionalization method can be still be
used to alter surface chemistry, while increased crystallinity will likely increase the
catalytic effect of the silica particle. Doping silica particles with metallic species might
also result in a better catalytic degradation effect while maintaining the biocompatibility
level of the composite as well. Since silica particle is easily modifiable, the possibility is
nearly endless.
In Chapter 4, Increasing or decreasing silica particle is also proved to drastically affect
the biological response both in vivo and in vitro (as demonstrated in Chapter 3 and 4).
However, the incorporation of the particle is seemingly more suitable for fine-tuning the
H2O2 concentration range than utilizing solely to control the high amount of H2O2. PEGDA formulation proved to be one of the biggest deciding factors for the composite
adhesive biological response as they are directly responsible for the H2O2 generation.
Modifying the adhesive formulation and structure, then fine-tuning the adhesive bulk
properties and H2O2 concentration level, could be a more effective approach to control
the cytotoxicity and biological response. The author firmly believes that combing all the
knowledge established in this dissertation would lead to a successful design of tissuespecific adhesive formulations with the ability to accelerate tissue repair.
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Appendix A.
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NMR Spectra of PEG-D6

PEG

Terminal
7 6 8

D2O

PEG
-CH2-O-

128

5

4

13

2

NMR Spectra of PEG-D8
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Prediction result from the robust design functions. The grey highlighted rows are the
selected formulation.
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